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ABSTRACT 
 
Background: The role of antioxidants and adequate nutrition in the prevention and course of 
cancer treatment is globally recognised in nullifying the effects of free radicals and increasing the 
nutritional status of children during treatment.  
Objective: To investigate whether children with cancer meet their Dietary Reference Values and 
Safe Intakes for antioxidants, energy and protein. 
Design: Single centre prospective study. 
Setting: Children were recruited from the East of England Primary Treatment Centre using 
convenience sampling over 8 months. Forty-two children and adolescents diagnosed with a Solid 
tumour, Lymphoma or Leukaemia were eligible for data analysis (n=20 male; n=22 female).  
Method: Data was collected with an Estimated Food Record (EFR) in the 1st (EFR1) and 3rd month 
(EFR2) post-diagnosis. In the week following EFR completion, parents and/or children were 
contacted to complete four non-consecutive days of 24-hr food recalls. Data was categorised into 
diet alone, diet + food supplement (FS), tube feeding (tube) or diet + multi-vitamin-mineral 
supplementation (VMS). Malnutrition was determined by weight-for-age z-scores. Nutrient intake 
was compared to the Recommended Nutrient Intake (RNI), the Estimated Average Requirements 
(EAR) and the Lower Recommended Nutrient Intake (LRNI). 
Result: The sample consisted of 33% (n=14) diagnosed with Leukaemia, 24% (n=10) with 
Lymphoma and 43% (n=18) with Solid tumours. Sixty seven percent (n=28) underwent 
chemotherapy and 33% (n=14) a combination of therapies. Significant correlations were seen 
between the assessment tools in the diet alone category for both months for; vitamins A, C, E, 
selenium and protein and for EFR1 for zinc and energy. In both months greater numbers of 
children achieved ≥100% of requirements for diet + VMS (EFR 1; p<0.05; EFR2 p<0.05) than for 
other feeding modes. Vitamin C achieved the highest intakes compared to the RNI at 773% 
(EFR1) and 829% (EFR2). Intakes above 200% of the RNI were seen for vitamins A, C, E, 
selenium and zinc. No significant differences were seen between modes of feeding in either month 
for selenium or zinc. Vitamin A (EFR1≤ 100% diet alone p<0.05) and zinc (EFR1≤ 100% diet alone 
p=0.02) met the least of the LRNI in the 1st month compared to other antioxidants. No statistical 
significant difference was observed between the number of children attaining their EAR’s between 
the 3 modes of feeding in the 1st month and 3rd month. In the 1st month 27% (n=8) of participants 
consumed vitamin and/or mineral supplements, 18% in the 3rd month (n=4). In the 1st month 5% 
(n=2) of children were moderately malnourished and 10% (n=4) in 3rd month. Conversely in the 1st 
month 3% (n=1) were overweight and 3% (n=1) obese; the leukaemia group predominant. 
Conclusion: The research tools showed good correlation. Children using vitamin and/or mineral 
supplements mostly achieved their RNI’s compared to other feeding modes. Across feeding modes 
some children achieved antioxidant intakes above 200% RNI. LRNI’s on diet alone were not 
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achieved for vitamin A and zinc. The study showed Leukaemics as having a higher prevalence of 
obesity. More research is required to determine the clinical implications of these findings.  
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OPSOMMING 
 
Agtergrond: Die rol van anti-oksidante en voldoende voeding in die voorkoming en verloop van 
kanker behandeling word wêreldwyd erken vir vernietiging van die effek van vry radikale en die 
verbetering van voedingstatus van kinders tydens behandeling. 
Doelwit: Om ondersoek in te stel of kinders met kanker hul Dieet Verwysingswaardes en Veilige 
Innames vir anti-oksidante, energie en proteïen bereik. 
Ontwerp: Enkel sentrum prospektiewe studie. 
Omgewing: Kinders was gewerf deur middel van gerieflikheidsteekproefneming oor 8 maande 
vanaf die “East of England Primary Treatment Centre”. Twee-en-veertig kinders en adolessente 
gediagnoseer met 'n Soliede tumor, Limfoom of Leukemie het in aanmerking gekom vir data-
analise (n=20 manlik, n=22 vroulik). 
Metode: Data was ingesamel met ‘n Geskatte Voedsel Rekord (GVR) in die eerste (GVR1) en 
derde maand (GVR2) na diagnose. In die week na voltooiing van die GVR is ouers en/of kinders 
gekontak om vier onopeenvolgende dae van 24-uur herroepe te voltooi. Data was verdeel in dieet 
alleen, dieet + voedsel supplement (VS), buisvoeding (buis) of dieet + multi-vitamien-mineraal 
supplementasie (VMS). Wanvoeding was bepaal deur middel van gewig-vir-ouderdom z-tellings. 
Nutriënt inname was vergelyk met die Aanbevole Nutriënt Inname (ANI), die Geskatte Gemiddelde 
Behoeftes (GGB) en die Laer Aanbevole Nutriënt Inname (LANI). 
Resultate: Die steekproef het bestaan uit 33% (n=14) gediagnoseer met Leukemie, 24% (n=10) 
Limfoom en 43% (n=18) Soliede tumore. Sewe-en-sestig persent (n=28) het chemoterapie ontvang 
en 33% (n=14) ‘n kombinasie van terapieë. Betekenisvolle korrelasies was waargeneem tussen 
die assesseringsinstrumente in die dieet alleen kategorie vir beide maande vir vitamiene A, C, E, 
selenium en proteïen en vir GVR1 ook vir sink en energie. In beide maande het ‘n groter aantal 
kinders ≥100% van hul behoeftes bereik vr dieet+VMS (GVR1; p<0.05; GVR2 p<0.05) as vir ander 
modi van voeding. Vitamien C het die hoogste innames bereik vergeleke met die ANI teen 773% 
(GVR1) en 829% (GVR2). Innames bo 200% van die ANI was waargeneem vir vitamiene A, C, E, 
selenium en sink. Geen betekenisvolle verskille was waargeneem tussen modi van voeding in 
enige maand vir selenium en sink nie. Vitamien A (GVR1≤100% dieet alleen p<0.05) en sink 
(GVR1≤100% dieet alleen p=0.02) het die minste van die LANI bereik in die eerste maand 
vergeleke met ander anti-oksidante. Geen statisties beduidende verskil was waargeneem tussen 
die aantal kinders wat hul GGB’s bereik het tussen die 3 voedingswyses in die eerste en derde 
maande nie. In die eerste maand het 27% (n=8) van deelnemers vitamien en/of mineraal 
supplemente ingeneem, en 18% (n=4) in die derde maand. In die eerste maand was 5% (n=2) van 
kinders matig wangevoed en 10% (n=4) in die derde maand. In die eerste maand was 3% (n=1) 
van kinders oorgewig en 3% (n=1) vetsugtig, die leukemie groep spesifiek. 
Gevolgtrekking: Die navorsingsinstrumente het goeie korrelasie getoon. Kinders wat vitamien 
en/of mineraal supplemente gebruik het het meestal hul ANI’s bereik vergeleke met ander modi 
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van voeding. Oor voeding modi het sommige kinders anti-oksidant innames bo 200% ANI bereik. 
LANI’s op dieet alleen was nie bereik vir Vitamien A en sink nie. Hierdie studie het aangetoon dat 
dié met Leukemia ‘n hoër prevalensie van oorgewig/vetsug getoon het. Meer navorsing is nodig 
om die kliniese implikasies van die bevindinge te bepaal. 
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 INTRODUCTION 
 
The role of antioxidants and adequate nutrition in the prevention and course of cancer treatment is 
globally recognised. This is due to the unique role antioxidants play in nullifying the effects of free 
radicals and the considerable benefits seen in well-nourished children and adults during cancer 
treatment.(1-3)  
 
It is known that cancer in itself, not withstanding cancer treatment, induces a high incidence of 
malnutrition. The incidence of malnutrition in children with cancer is said to range from 6% to 50% 
depending on the type, stage and location of the tumour.(4,5) Malnutrition has been shown to result 
in a poorer outcome compared to a well-nourished child at diagnosis and during treatment.(2,6,7) 
Although the importance and benefits of optimal nutritional status during treatment is known 
equally the dilemma lies in providing a sufficient or excessive intake of antioxidants that could 
compromise the efficacy of cancer treatment itself.(5,8-12) Antioxidants have the potential to reverse 
the cancer treatment’s action of increasing free radical production and killing cancer cells.(3) There 
are numerous adult studies showing the effects of antioxidants in cancer treatment however there 
are still very few in the paediatric population.(6) Currently few paediatric studies exist looking at the 
effects of antioxidants in cancer treatment. Though many adult studies exist it is often difficult to 
extrapolate data due to the different nature of cancer types, treatments, requirements of 
antioxidants and also taking into account factors such as the different ages of the child. 
Consequently very little data providing actual references for the requirements of antioxidants 
during cancer treatment for a child is available. Authors have proposed that there is a clinical need 
for increased intakes of antioxidants compared to the Recommended Dietary Allowance (RDA), 
Recommended Nutrient Intake (RNI) and Estimated Average Requirement (EAR) during cancer 
treatment; however there are no studies available to substantiate what these requirements should 
be.(12) 
 
The main aim of providing this increased nutritional support in the cancer patient is to promote and 
achieve desirable weight gain and to prevent or correct nutritional deficiencies. Individualised 
counselling on the potential nutritional problems related to the location of the tumour and cancer 
staging is discussed with the patient and family. The implications of malnutrition in comparison to 
well-nourished children during treatment are noteworthy. Children on intense treatments are at 
higher risk of nutritional morbidity as well as higher infection rates, worse outcomes, impaired 
tolerance to chemotherapy, impaired immune function and the need for more frequent 
chemotherapy dose adjustments.(5,8-10,12-14) All of these risk factors a significant impact on length of 
treatment, number of admissions, quality of life, the efficacy of treatment and hence outcome as 
well. It could therefore be suggested that adequate nutritional support improves overall outcome in 
the paediatric oncology patient with regard to patient outcome and cost to the National Health 
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Service (NHS). As such the chairman of the British Association for Parenteral and Enteral Nutrition 
(BAPEN UK) stated that ‘Good nutritional care also makes sound financial sense. BAPEN has 
estimated that public expenditure on malnutrition in the UK in 2007 was over £13 billion and so 
consequently improved nutritional care could result in substantial financial returns; a 1% saving 
could amount to approximately £130 million per year. These results are also inclusive of adult data. 
Therefore not only are we mindful of the implications it has for the actual patients outcome but for 
the NHS service as well.(15) 
The supplementation of antioxidants during cancer treatment remains a controversial topic. The 
possible benefits of antioxidants for a child during cancer treatment seem intuitive, yet the 
implications of negating this very treatment could offer a poorer outcome. Due to the limited data 
available to support the recommendation and level of dosing of antioxidants during cancer 
treatment, it leaves this topic in a state of controversy. Kennedy et al.(11) advised that 
supplementation during treatment of antioxidants was not advocated due to the probable 
interference with cancer treatment, even though their study showed that the population group did 
not meet recommended dietary intake.  
This study therefore set out to establish the actual dietary intake of antioxidants in this paediatric 
oncology population. The purpose was to determine whether the children were meeting the United 
Kingdom Department of Health’s (DOH UK) antioxidant, energy and protein requirements for 
healthy children,(16) which is needed to maintain normal body functioning. No national guidelines 
exist for the requirement of antioxidants in the paediatric oncology population. Further to this the 
prevalence of vitamin-mineral supplementation and the doses given were investigated to establish 
over and under supplementation. From the latter investigations one could hypothesise whether 
there was the potential that excessive amounts of antioxidants could interfere with treatment.  
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1.2 ROLE OF REACTIVE OXYGEN SPECIES AND ANTIOXIDANTS IN CANCER  
      TREATMENT 
 
It is important to understand the unique role that antioxidants play in the neutralization of free 
radicals and how this impacts on a child’s tolerance and response to cancer treatment. An 
antioxidant is defined as a substance that inhibits the reactions of free radicals such as reactive 
oxygen species (ROS).(17) This is used to describe vitamin A, E, C, ubiquinones and 
bioflavonoids.(17) The antioxidants and units of measurement researched in this study are 
documented in Table 1.1. 
 
Table 1.1 Antioxidants and/or derivatives and unit of measurement 
Antioxidant Derivative Measurement unit 
Vitamin A Retinol equivalents ug (microgram) 
Vitamin E α– tocopherol mg (milligram) 
Vitamin C/ascorbic acid N/A mg (milligram) 
Zinc N/A mg (milligram) 
Selenium N/A ug (microgram) 
 
On the other hand reactive oxygen species (ROS) are metabolites of molecular oxygen and are 
constantly produced in our cells (Figure 1.1).(15) ROS includes superoxide anion radical (O2-.), 
singlet oxygen (1O2), hydrogen peroxide (H2O2), nitric oxide (NO+) and the highly reactive hydroxyl 
radical (OH). Free radicals are said to damage cells and may contribute to the development of 
cancer and cardiovascular disease.(18) 
 
Reactive Oxygen Species (ROS) 
O2-  Superoxide+ 
H2O2  Hydrogen Peroxide 
OH+  Hydroxyl Radical 
 
Reactive Nitrogen Species 
NO+  Nitric Oxide 
NO2  Nitrogen Dioxide 
ONOO Peroxynitrite 
 
Figure 1.1 Main reactive oxygen species constantly generated in living cells.(3) 
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These ROS are produced through mitochondrial respiration involving the electron transport chain 
and the reduction of oxygen molecules to superoxides.(15) Alternatively, hydrogen peroxide can be 
converted into water by the enzyme catalase or glutathione peroxidase. Sources of exogenous 
sources of free radicals include chemicals, pollutants, ultra violet (UV) and radiation (Figure 1.2).(3) 
 
                  
Figure 1.2 Schematic representations of pathways illustrating sources of reactive oxygen species 
and role in the development of cancer(19)  
 
 
Reactive oxygen species 
 
Oxidative stress 
 
Damage to nucleic acids, 
proteins and lipids 
Chromosomal instability 
Mutations 
Loss of organelle functions 
Membrane damage 
                 Cancer 
       Exogenous sources 
UV light 
Ionizing radiation 
Inflammatory cytokines 
Pathogens 
 
Endogenous sources 
Mitochondria 
Peroxisomes 
Cytochrome 450 
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ROS are renowned for its role in causing tissue damage by reacting with lipids in cell membranes, 
nucleotides in DNA (Deoxy-ribose nucleic acid), sulphydryl groups in proteins and cross-linking 
fragmentation of ribo-nucleoproteins (RNA). This is generally seen when the internal equilibrium of 
ROS redox balance is disturbed (Figure 1.2).(20-22) However, ROS are not always harmful if tightly 
controlled at moderate levels. At these moderate levels ROS functions effectively in intracellular 
signalling molecules and in apoptosis, phagocytosis and detoxification reactions (protective 
mechanisms).(3,19) Apoptosis occurs when the internal body detectors recognise damage or 
malfunction and initiate signalling cascades that eventually activate caspases and endonucleases 
that kill the cell. The most significant function of apoptosis is the elimination of pre-cancer and 
cancer cells; however antioxidants such as α-tocopherol (vitamin E) and others have the potential 
to inhibit apoptosis (Figure 1.3).(23) This has been demonstrated in animal studies performed at the 
University of North Carolina at Chapel Hill. Transgenic mice developing brain tumours were fed a 
diet depleted of antioxidants, while control mice were fed a standard diet. The antioxidant-depleted 
group showed a significant increase in ROS in their brain tumour cells and therefore a dramatic 
increase in apoptotic death of these cells. Due to the intensive apoptosis, a sharp decrease in 
tumour volume resulted. Similar results were obtained in transgenic mice developing mammary 
tumours. This data indicates that antioxidants scavenging ROS can interfere with cancer cell-killing 
apoptosis.(24)  
 
In general, normal human cells contain antioxidant enzymes (e.g. superoxide dismutase, catalase, 
and glutathione peroxidase). This is in contrast to human cancer cell types that characteristically 
have lower antioxidant enzyme levels, but instead have significantly higher concentrations of ROS. 
It is therefore thought that some cancer cells may be more sensitive to changes of generated ROS, 
which could then be utilized when actively seeking to kill cancer cells and spare normal cells. This 
is evidenced in the use of certain chemotherapy agents used to overcome the oxidative stress 
mechanisms of the cancer cell by increased production of ROS.(25) Many classes of anticancer 
agents are known to produce a high level of oxidative stress in biological systems.(20,26) These 
drugs include the anthracyclines (e.g. Doxorubicin), platinum-coordination complexes (e.g. 
Cisplatin, carboplatin), epipodophyllotoxins, most alkylating agents (e.g. Cyclophosphamide, 
Ifosphamide), and cytotoxic antibiotics (e.g. Bleomycin, mitomycin-C).(11,19,27) Other drug classes 
such as taxanes, vinca alkaloids, anti-folates and nucleosides only generate low levels of free 
radicals.(28)  
 
In contrast radiation’s main therapeutic effect occurs indirectly via the ionization of water molecules 
in the cytoplasm to ROS for example superoxide and hydroxyl radicals. These free radicals react 
with nuclear DNA, therefore forming structural bonds that are potentially fatal to cells. Cancer cells 
have the ability to repair radiation damage; therefore cells that remain viable can proliferate. This 
shows the importance of combination therapies in the treatment of cancer.(29) This poses a difficult 
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decision for health care professionals as to whether adequate antioxidants in the diet and/or 
supplementation should be advocated or not. Its ability in improving tolerance of treatment is 
known; however at the same time one has to be conscious of the effects it has on vital treatment. 
 
 
 
 
 
 
` 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 ROS – reactive oxygen species 
Figure 1.3 Schematic representation of apoptosis and antioxidants in cancer treatment  
ROS1 functions in apoptosis, 
phagocytosis and detoxification 
 
If cancer cells persist, cancer drugs 
and radiation are given to increase 
ROS production in the cancer cell to 
kill it 
 
 
Anti-cancer drugs 
e.g. anthracyclines  
Apoptosis occurs when damage or 
malfunction is recognized by bodily 
monitors 
Initiates signalling cascades which 
activate caspases and 
endonucleases  
Antioxidants can neutralize the 
increased ROS1 production by 
radiation and chemotherapy 
 
 
Radiation 
Generation of ROS1 in healthy 
cells is tightly controlled 
Eliminates pre -cancer 
and cancer cells 
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Taking into account all the processes that antioxidants are involved in it would be reasonable to  
hypothesise that antioxidants could become depleted if not adequately replenished. This is 
supported by the following studies: a systematic review performed by Ladas et al.(6) supported the 
hypothesis that chemotherapy lowered total antioxidants status, but this was assessed in a limited 
number of observational studies only and no randomized control trials. Malvy et al.(26,30) showed 
that in general, the mean serum concentrations of retinol, β -carotene, zinc, α-tocopherol, and 
cholesterol were lower in cancer cases than controls; however there were some differences in 
micronutrient deficiencies by tumour type. It was suggested that this could be attributed to changed 
biosynthesis in the liver high receptor mediated intake and degradation by malignant cells, 
production of ROS by radiation and chemotherapy, inadequate intake and activated 
granulocytes.(20) Interestingly when higher plasma concentrations of Oxygen Radical Absorbance 
Capacity (ORAC), vitamin A, E, total carotenoids and 8-oxodeoxyguanosine were seen in children 
with Acute Lymphoblastic Leukaemia (ALL) a positive association was found with fewer infections 
improved quality of life, decreased toxicity and decreased length of admission.(4,7,11)  
 
Very few studies had investigated the role of selenium and zinc as antioxidants in the paediatric 
oncology setting. Studies that were available found that at diagnosis children had low serum 
selenium values except for those on corticosteroid treatment, who had raised selenium levels.(31-33)  
It was concluded that selenium deficiency was common among newly diagnosed children with 
cancer and lower in widespread disease than localized disease.(32,33) It was suggested by Koskelo 
that the endogenous selenium store redistributed itself later in the treatment period therefore 
serum selenium may not be a valid indicator of selenium status.(31) In the case of zinc it was found 
that long-term deficiency was associated with malignant lymphomas (Burkitts and Hodgkin’s) and 
that this persisted for years. The study showed that tumour necrosis factor-α and interleukin 1–β 
increased in zinc deficient cells therefore causing activation of monocytes and macrophages 
involved in ROS generation. It was therefore thought that zinc could function as an effective 
antioxidant.(34) Interestingly in the study by Gokhale on the post therapy profile of serum retinol, 
zinc and serum total cholesterol, it was found that children had comparable serum levels to that of 
controls.(35) Therefore cancer and its treatment did not have any long-lasting effect on the latter 
nutrients.  
 
Despite ongoing research on the effect of antioxidants on cancer treatment, a systemic review of 
randomized trials by Ladas et al.(6) could not draw a definitive conclusion as to the safety and 
efficacy of antioxidant interventions. This was most probably due to the broad range of 
chemotherapy regimes, antioxidant supplementation and cancer diagnoses.   
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1.2.1  CONCLUSIONS: ROLE OF REACTIVE OXYGEN SPECIES AND ANTIOXIDANTS IN 
CANCER TREATMENT 
 
At this stage most oncologists and dietitians would still discourage children and parents from using 
antioxidants as additional supplements during treatment due to the controversial nature of 
antioxidants and cancer treatment.(25) There is consequently a great dilemma: a child requires 
adequate antioxidants to meet and not exceed the RNI during cancer treatment, however oral 
intake is compromised and deficiencies are common during treatment. Should healthcare 
professionals therefore recommend antioxidant supplements to achieve RNI’s but risk interfering 
with the treatment? 
 
 1.3 NUTRITION IN THE CHILD WITH CANCER 
 
1.3.1 REQUIREMENTS FOR ANTIOXIDANTS, ENERGY AND PROTEINS 
 
Due to the limited data available for the requirements of antioxidants in the paediatric oncology 
patient, it would be reasonable to use the DOH (UK) report outlining the Dietary Reference Intakes 
(DRV) for children.(16) Though much of this work is extrapolated from adults and is based on 
healthy individuals, it still provides a baseline for assessing this study’s antioxidant intakes. It is still 
worthy to note that these requirements do not take into account different disease processes and 
how this may affect the requirements. The report by the DOH (UK) in 1991 defines the DRV as 
comprising of the following components namely; Estimated average requirement (EAR), 
Recommended nutrient requirement (RNI) and Lower recommended nutrient intake (LRNI). Each 
of these nutritional requirement categories are said to fulfil specific parameters in a healthy 
population of children. In this study the RNI will be used to compare the children’s daily nutritional 
intakes. The RNI is suitable to estimate the intake of individuals so as to meet 97.5% of healthy 
individuals in a population group’s requirements.(16) Depicted in Figure 1.4 is an illustration of how 
the dietary reference values meet the populations’ requirements.(16)  
 
Stellenbosch University  http://scholar.sun.ac.za
10 
 
 
Figure 1.4 Definitions of Dietary Reference Values.  
                  (Reprinted with permission from the Department of Health (UK)(16) 
 
As reported by the DOH (UK),(16) data is usually insufficient to calculate the exact distribution of 
requirements in a group of individuals for a nutrient, therefore it is assumed to be normally 
distributed (Figure 1.4). This gives an assumed/notional mean requirement or EAR with the inter-
individual variability in requirements as seen in Figure 1.4. The panel for the DOH (UK) defined the 
RNI as point c in the distribution that is two notional standard deviations (2SD) above the EAR 
(point b). Intakes above this amount will almost certainly be sufficient. A further value at point a, is 
two notional standard deviations (2SD) below the mean, the Lower Reference Nutrient Intake 
(LRNI). This represents the lowest intake of a nutrient that will meet the needs of some individuals 
in the group.  If the usual/habitual intake of the child is below the LRNI it is unlikely that the child 
will be consuming adequate amounts of the nutrient to maintain the function as an appropriate 
parameter of nutritional status for that nutrient. If the intake lies between the two (b and c), then the 
chance of the intake not meeting the requirement decreases the closer the intake to the RNI. 
Without some biological measure, it is impossible to say without any doubt whether an individuals’ 
nutrient intake is adequate, if it lies between the LRNI and the RNI.(16) Due to the inaccuracy of 
most estimates of individuals’ nutrient intakes and the assessment of nutritional status; it is 
important to use caution when using the estimated DRV’s against an individual’s.(16) A summary of 
each antioxidants function, source, and nutritional state is shown in Addendum A. The DRV’s for 
vitamin A, C, selenium, zinc and safe intake for vitamin E are shown in Addendum B and EAR for 
energy and protein in Addendum C. The fat-soluble vitamins (A and E) intakes were also 
compared against the Safe Upper Intakes (Addendum D).  
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From the latter discussions we gain an appreciation of the potential and significant effects of 
antioxidants. This is not only in daily tightly regulated body processes, but its ability to neutralize 
ROS could improve a child’s quality of life and nutritional morbidity during treatment. We are 
however thwarted by the fact that antioxidants can also impact on cancer treatments efficacy. To 
date health care professionals are still reluctant to supplement with antioxidants for the very fear of 
interfering with cancer treatment. Limited data exists in paediatric oncology patients with regard to 
studies providing varied doses of antioxidants to patients to determine the threshold whereby 
interference with cancer treatment is seen. In this study we will scrutinize the children’s actual 
dietary intakes and compare these to the recommendations of healthy children. This will include 
the LRNI, RNI, DRV and safe intakes.(16) It would be reasonable to assume that even though these 
children are on cancer treatment they should meet at least the LRNI and RNI and DRV for healthy 
body functioning and that there may be an increased requirement due increased ROS production 
during treatment and by the disease itself. This study will also elicit if any children are consuming 
excessive intakes compared to the recommendations.  
 
1.3.2 AETIOLOGY OF MALNUTRITION 
 
Severe malnutrition is more commonly seen in newly diagnosed children, relapse solid tumours 
and the later stages of cancer as cited by Ward.(1) The implications of malnourished children in 
comparison to their well-nourished counterparts during treatment are noteworthy. Children on 
intense treatments are at higher risk of nutritional morbidity as well as higher infection rates, worse 
outcomes, impaired tolerance to chemotherapy, impaired immune function and the need for more 
frequent chemotherapy dose adjustments. All of the latter have a significant impact on length of 
treatment, number of admissions, quality of life, efficacy of treatment and outcome.(5,9-14,36)     
 
Malnutrition seen in both paediatrics and adult cancer patients is called cancer cachexia. This 
syndrome of progressive body wasting is characterized by loss of adipose tissue and skeletal 
muscle mass. Cachexia was shown to be more common in children with solid tumours at 
presentation (33%) and during treatment (57%) compared to children with leukaemia (12% at 
presentation, 28%, during treatment).(37) It is also known that factors that contribute to an impaired 
nutritional status include reduced food intakes, alterations in nutrient metabolism and an increased 
resting expenditure. Children’s food intakes whilst on cancer treatment are sensitive to the ‘wax 
and wane’ of treatment intensity, the systemic and adverse effects as well as psychological 
elements associated with cancer treatment. Though cancer cachexia is not fully understood; 
studies have shown that cytokines are involved in the aetiology and are important in the alteration   
of carbohydrate, lipid, and protein metabolism. Cytokines such as tumour necrosis factor, 
interleukin 1, 6 and y-interferon are thought to play a role in cancer cachexia, however the exact 
role is not yet known.(38,39)  
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The normal response expected to starvation is to conserve energy and protein reserves at the 
expense of endogenous carbohydrate and fats stores. This compensatory mechanism does not 
occur in the person with cancer. Despite a decreased protein intake the body’s protein turnover 
increases and hence muscle catabolism takes place. Clinically this is seen as skeletal muscle 
atrophy and hypoalbuminemia.(37,40) Deranged changes are also seen in lipid metabolism with a 
reduction in lipid stores, an increase in circulation and increased fatty acid turnover. Marked 
wasting of body fat and atypically raised plasma lipids are therefore observed. Increased insulin 
resistance and gluconeogenesis contributes to the irregularities in carbohydrate metabolism and 
subsequent increased glucose turnover and impaired glucose tissue clearance.(37,40) During cancer 
treatment children have increased protein and energy requirements to maintain growth, which 
places them at greater risk of malnutrition.(39)  
 
1.3.2.1 IDENTIFYING A CHILD AT RISK OF MALNUTRITION 
 
The main aims during cancer treatment are to promote growth as well as prevention and reversal 
of malnutrition. To enable this, the use of nutritional support is required throughout the cancer 
treatment. Consequences of malnutrition are multiple and therefore nutrition guidance measures 
(Table 1.2) were developed from the two publications by Rickard et al.(41,42) The purpose of the 
guidance measures was to categorise children according to tumour type and staging and 
subsequently whether this classed the child at high or low nutritional risk.(41,42)  
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Table 1.2 Types of childhood cancers associated with nutritional risk (41,42) 
 
High Nutritional Risk Low Nutritional Risk 
 
Advanced diseases during initial intense 
treatment 
Stages III and IV Wilm’s tumour and 
unfavourable histology Wilm’s tumour 
Stages III and IV neuroblastoma 
Ewings sarcoma 
Pelvic rhabdomyosarcoma 
Some Non-hodgkin’s lymphoma 
Multiple relapse leukaemia 
Acute non-lymphoblastic leukaemia 
Some poor prognosis Acute lymphoblastic 
leukaemia 
Medulloblastoma 
 
Good prognosis Acute lymphoblastic 
leukaemia 
Non- metastatic Solid tumours 
Advanced diseases in remission during 
maintenance treatment 
 
A further useful tool to measure acute malnutrition is that of weight-for-height and weight-for-age z-
scores provided by the World Health Organization Global Database on Child Growth and 
Malnutrition.(43) This database uses a z-score cut-off point of <-2 Standard deviations (SD) to 
classify low weight-for-age, low height-for-age and low weight-for-height as moderate and severe 
under-nutrition as <-3 SD to define severe under nutrition. A disadvantage of weight-for-age is that 
it fails to distinguish between short children of adequate body weight and tall, thin children. 
Therefore where possible weight-for-height should be used.(43,44) 
 
Tools to measure growth and remission are further discussed in publications by Kennedy et al. and 
Khan et al.(11,13) A lower weight-for-height was found to be associated with a shorter remission 
period in particular to ALL populations. This was however not conclusively seen in a follow up 
study. Though this data was seen in particular with ALL populations, it could reasonably be 
extrapolated to most high risk cancers.(11) Khan et al.(13) did not find conclusive evidence to suggest 
that weight-for-height is a significant prognostic tool for prognostic significance. Weight-for-height 
z-scores were the preferred tool to determine malnutrition in children with cancer, however in this 
research study weight-for-age was used. The reason for this was that not all the children were 
heighted on the unit in particular the 1-3 year age group, those that were immobile, and neuropathy 
induced by vincristine.  
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1.3.3 NUTRITION SUPPORT IN THE CHILD WITH CANCER 
 
Nutritional support can be defined as the provision/administration of nutrients in place of or in 
addition to that provided by normal eating to ensure a balanced diet. This includes interventions 
relating to the methods of delivery (e.g. via enteral tube feeding or parenteral route) and/or 
nutritional content (e.g. high density). El-Mantary,(45) suggested that aggressive nutritional support 
was essential in improving the outcome in cancer patients in catabolic states. However, it is often 
difficult to establish adequate oral feeding despite energy dense supplements due to the underlying 
malignancy, in addition to the aggressive chemo- and radiotherapy. A child with cancer is largely 
assessed against the criteria recommended by Andrassy to determine if nutritional support is 
required.(39) Based on this assessment the appropriate route of nutritional support is initiated. 
Criteria are as follows:(39) 
a) Five to ten percent weight loss relative to pre-illness body weight. 
b) Weight-for-height less than 90%. 
c) A decrease in current centile in weight by 2 percentile. 
d) Adipose energy reserve as determined by skin fold measurement be < 50th centile for 
age and gender. 
e) Voluntary food intake of <70% of estimated requirement for 5 days in the well-nourished 
child. 
f) High nutritional risk dependent on tumour type and site. 
g) Bone marrow transplantation. 
h) Anticipated gut dysfunction due to treatment for 5 days in well-nourished children 
(parenteral nutrition). 
 
Oral feeding is generally recommended as the first option of feeding especially for children with a 
low nutritional risk (Table 1.2); with the exception of those with complications such as relapse, 
sepsis or major abdominal procedures. The latter children may however require nasojejunal or 
parenteral feeding dependent on the site of trauma. Children on less intensive treatments generally 
don’t require tube feeding or parenteral nutrition, but may require energy dense oral supplements 
accompanied with a multivitamin-mineral supplement. This is potentially due to poor eating, 
decreased variety, limited fruit and vegetable intake and slowed weight gain.(1)  
 
Tube feeding is provided to those patients with suboptimal intake. Nasogastric and nasojejunal 
tubes were most frequently used for shorter term feeding whereas gastrostomy and jejunostomy 
feeding were suggested for longer term feeding and certain cancers in which high dose treatment 
was frequent and associated with vomiting.(45) Parenteral nutrition is reserved for those children 
whose enteral feeding regimens cannot provide adequate nutrition, in particular children with 
abnormal gastrointestinal function that is related either to the tumour or a side effect of 
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treatment.(1,46) In comparison to parenteral feeding, enteral nutrition is considered to be more 
practical, has a lower risk of infection, maintains gut integrity and reduces the risk of bacterial 
translocation.(1,4) Sala et al.(47) and Jeejeebhoy supported enteral feeding in this cohort of patients 
and also mentioned that the enteral route had a greater safety, ease of administration, was more 
physiologic with an efficient use of nutrient substrates, decreased hepato-biliary complications and 
improved outcome and cost-effectiveness.(48) Though infrequently used parenteral nutrition serves 
its purpose of providing sufficient nutrients to children with abnormal gastrointestinal function 
related to their tumour or following chemotherapy or radiotherapy treatment.(1) It does however 
coincide with an increased infection risk and a supposedly could enhance tumour cell growth.(49,50) 
A study by Christensen et al.(50) showed the risk of infection was 2.4-fold greater in patients given 
parenteral nutrition (95% confidence interval 1.5 to 3.9; p< 0.001).  
  
It became evident from a study performed in three paediatric oncology units that children with 
specific cancer types and bone marrow transplants became severely malnourished during 
treatment due to significant nausea and vomiting.(51) This had obvious implications for nasogastric 
feeding, and therefore Percutaneous Endoscopic Gastrostomies (PEG’s) were placed at an early 
stage in treatment to prevent malnutrition.(51-53) The children in particular with Medulloblastomas 
showed a great benefit with the early placement of PEG’s and starting enteral nutrition at an early 
stage of treatment.(51) Children with Medulloblastomas are prone to vomiting, constipation and 
develop significant nutritional problems during treatment. Treatment centres in which proactive 
nutrition was initiated and prophylactic gastrostomies were sited showed a superior nutritional 
outcome.(51)  
 
1.3.4 CONCLUSION: NUTRITION OF THE CHILD WITH CANCER 
 
From the literature review it can be surmised that antioxidants have a controversial role to play 
during cancer treatment. Two particular schools of thought have arisen; antioxidants play a 
beneficial role in improving cancer treatment tolerance at normal and supplemented levels 
(reduces infections and less frequent delays in treatment) whereas the other school of thought is 
that antioxidants may interfere with the efficacy of certain cancer treatments. 
 
From the literature review it can be concluded that cancer-induced antioxidant depletion may be 
associated with: 

 Increased utilization by the tumor itself or the resulting oxidative stress. 

 Chemotherapy/radiotherapy per se may induce oxidative stress and hence increase the 
utilization and need for antioxidants. 
 
Stellenbosch University  http://scholar.sun.ac.za
16 
 
Few studies exist for the investigation into the intake of antioxidants in children and adolescents 
with cancer. Parents frequently question the use of vitamin-mineral supplementation (VMS) during 
treatment especially additional antioxidants intake in the form of food or supplementation and 
general advice on providing foods with antioxidants is sought. Therefore such research would be 
invaluable in determining the trends of energy, protein and antioxidant intake in children and 
adolescents the categories of Solid tumours, Lymphomas and Leukaemia that will enable health 
care professionals to provide proactive and effective advice during treatment.    
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CHAPTER 2: METHODOLOGY 
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2.1 STUDY OBJECTIVES 
 
2.1.1 RESEARCH PROBLEM 
 
The adequacy of antioxidant consumption in children and adolescents with Solid tumours, 
Lymphomas and Leukaemics on treatment: an investigation into vitamin A, E, C, zinc and selenium 
consumption in paediatric patients that attended the East of England Primary Treatment Centre 
(Cambridge University Hospitals NHS Foundation Trust, England). 
 
2.1.2 RESEARCH AIM AND SPECIFIC OBJECTIVES  
The aim of the study was to investigate whether the paediatric patient with a Solid tumour, 
Lymphoma or Leukaemia were meeting their RNI for antioxidants (vitamin A, C, E, selenium and 
zinc) whilst undergoing cancer treatment. The specific objectives that were investigated were as 
follows (Figure 2.1):  
a.) To determine the total daily antioxidant intake by means of a 4-day estimated food record (EFR 
– primary research tool) and 24hr recalls (verification tool) as follows: 
 Tube feeding with/without oral feeding and with/without VMS and/or antioxidant 
supplements. 
 Oral diet with and without VMS and/or antioxidant supplements. 
b) To determine the following regarding antioxidant intake: 
 Comparison with age appropriate RNI’s (including the standard deviation of daily 
antioxidant intake from the RNI). 
 Whether the fat-soluble antioxidants (vitamin A and E) are exceeding the Safe Upper Intake 
per day based on the Joint Food and Agricultural Organization of the United Nations and 
recommended by DOH (for further information see Addendum D).(16,54) 
 The prevalence of VMS and/or antioxidant supplements use. 
 The types of VMS used. 
c) Compare each child and adolescents daily total energy and protein intake to his/her age   
     appropriate RNI. 
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1 Estimated food record                                        
2 Vitamin and/or mineral supplement 
3 Standard deviation determined from Recommended Nutrient Intake (RNI) 
 
Figure 2.1 Diagrammatical representation of the specific objectives 
 
ANTIOXIDANT INTAKE  
(vitamin A, C, E, zinc and selenium) 
 
Measured by 4-day EFR1 and verified by 
3 repeated 24-hr recalls 
Comparison with 
age appropriate 
RNI3  
Determine if 
antioxidant 
intake 
exceeding safe 
upper intake 
Tube feeding with/without oral feeding 
and with/without VMS2/antioxidant 
supplements 
 
Oral diet with/without 
VMS2/antioxidant supplements 
 
Prevalence and 
types of 
supplements 
used 
 
Compare children 
and adolescents’ 
daily total energy 
and protein intake 
to appropriate1 
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2.2 STUDY DESIGN OVERVIEW 
 
The study was a single centre prospective study investigating the antioxidant intake of paediatric 
oncology patients who were undergoing treatment. 
 
2.2.1 STUDY POPULATION 
 
2.2.1.1 SELECTION OF SAMPLE 
 
The study population included all children and adolescents living in the East Anglia area in England 
that were diagnosed with Solid tumours, Lymphomas or Leukaemia. The study population attended 
the East of England Primary Treatment Centre (Cambridge University Hospitals NHS Foundation 
Trust, England). The subjects were predominately English speaking, aged between 1 to 16 years 
and were sampled by means of convenience sampling. In the event that patients declined to 
continue in the study; further patients were recruited to ensure that a sample of greater than and 
equal to a total of 48 patients were recruited in the whole study.  
 
2.2.1.2 SAMPLE SIZE 
 
The sample size was calculated based on the 2006 Paediatric Haematology/Oncology Annual 
Report from Addenbrookes Hospital; Cambridge University Hospitals NHS Trust. The Paediatric 
Haematology/Oncology unit averaged 6 newly diagnosed children and adolescents with 
Lymphomas and Solid tumours per month and therefore a time period of between 6-8 months for 
data collection was set dependent on the numbers obtained in this time. Data collection 
commenced June 2008. The aim was to recruit about 48 children and adolescents, which equated 
to approximately half of the total population of Lymphomas and Solid tumours diagnosed at this 
unit per year. However, during the study the inclusion requirements were adjusted allowing for 
other types of cancer to be included due to slow patient recruitment. Data collection was estimated 
to take 5-7 months, however during the first 3 months; only 8 children and adolescents had been 
recruited in the Solid tumour and Lymphoma diagnosis group. Factors contributing to the slow 
uptake were the low frequency of admissions to hospital during the first month of data collection as 
well as parents’ slow progress in returning food records even with frequent prompting. One further 
factor was the lower rate of diagnosis in comparison to 2006/2007, which could not be anticipated. 
The original motivation for the study was to focus on the Solid tumour and Lymphoma groups, as 
there was less evidence than that for leukaemia. Due to limited recruitment the study was 
expanded to incorporate the Leukaemia cancer group to ensure adequate recruitment within the 
allocated time frame. The recruitment criteria for the study were as follows: 
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Inclusion Criteria 
 
 Children and adolescents (male and female) 
 Receiving ‘active’ cancer treatment (chemotherapy and radiation therapy) at the Cambridge 
University Hospital NHS Trust. All Solid tumours, Lymphomas and Leukaemia types were 
included including children and adolescents with:  
o Solid tumours: Brain, Wilms, Primitive Neuro-ectodermal tumour Rhabdomyo-, 
Osteo- and Ewings sarcoma, and Neuroblastoma 
o Lymph cancer: Hodgkin, Non-Hodgkins and Burkitts lymphoma  
o Acute lymphoblastic leukaemia 
o Acute myeloid leukaemia 
 Age 1 -16 years.  Adolescents above 16 years of age are treated under the Adult Oncology 
services. 
 Parent/guardian and/or family member need to be literate in English to enable the 
completion of the research tools at home i.e. estimated food record.  
 
Exclusion criteria 
 
 Children and adolescents receiving palliative care, however those who were subsequently 
diagnosed as palliative after the data had already been collected were still included in the 
results.   
 Any inpatients, as food records were required to be completed once the child and 
adolescent was discharged from the hospital. Periods of time spent in hospital were not 
reflective of a normal intake due to infections, chemotherapy and associated 
nausea/vomiting and diarrhoea or Neutropenic Enterocolitis. 
 Children and adolescents on home parenteral nutrition. 
 Breastfed infants and toddlers, as volumes of breast milk consumed cannot be measured.  
 Less than 1 year of age. At this age it was difficult to determine intake of weaning foods due 
to messy mealtimes and reflux or vomiting of feeds upon burping of infant. 
 No informed consent obtained. 
 
The children and adolescents who took party in this study will be referred to as ‘child and children’ 
from this point forward. 
 
2.3 METHOD OF DATA COLLECTION  
 
The specialist oncology dietitians informed the researcher of the newly diagnosed children with 
Solid tumours, Lymphomas and Leukaemia upon verbal consent from the child/parent/guardian. 
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The researcher made contact with the child/parent/guardian on the ward or outpatient clinic at 
Addenbrookes Hospital within 1 month of diagnosis. The information provided at the first 
consultation included an invitation letter (Addendum E) with a brief description of the study as well 
as information sheets for the following age categories: parents/guardian, less than 5 years, 6-10 
years and 11-16 years (Addendum F). Parents/guardians were given 2 weeks to consider whether 
to give consent or not.  
 
If the child/parent/guardian decided to participate in the study, the researcher arranged for written 
consent to be obtained. The original copy of the consent form was kept with the researcher in a file 
locked in the Nutrition and Dietetic Department, at Addenbrookes Hospital. A further copy of the 
consent form was also placed in the child’s medical notes and the parent/guardian could also 
request a copy (Addendum G). Once consent was obtained the researcher provided oral and 
written information on the correct completion of the Estimated Food Record (EFR) (Addendum H), 
24-hour (hr) recalls (Addendum I) and use of the food portion size photographs. The child’s details 
were documented once parents of the child had consented to partake in the study. These details 
were logged into an excel spreadsheet as follows; hospital number, date of birth, diagnosis, start 
date, type of treatment, telephone number and if they decided to withdraw from study. Each child’s 
hospital number was allocated an identification number to maintain confidentiality of child’s data.  
 
In the 2nd week after discharge from hospital, the parent/guardian was contacted via telephone by 
the researcher to complete the 24-hr recalls (reference method) on alternate days i.e. on the 
Monday (for Sunday intake), Wednesday (for Tuesday intake), Friday (for Thursday intake), and 
Sunday (for Saturday intake). The parents were informed of the date on which the 24-hr recalls 
were to start. The EFR was completed the following week (3rd week after discharge from hospital). 
By completing the 24-hr recalls the week before the EFR, it prevented parents from ‘reading off’ 
the EFR that they have just completed therefore improving the accuracy of the results. According 
to Gibson it is recommended practice to complete 24hr recalls on non-consecutive days (as was 
implemented in this study).(55) The 24-hr recalls and EFR were repeated 3 months later during 
treatment using the same sequence.  
 
Each child received one 4-day EFR with a prepaid envelope at the first consultation and a further 
EFR was sent out 3 months later. The EFR was completed in the home environment, and not in 
the hospital setting (i.e. ward). This was due to the child’s food and fluid intakes changing 
dramatically in admissions due to chemotherapy and/or radiotherapy and associated 
nausea/vomiting, diarrhoea, infections or neutropenic enterocolitis, therefore giving a skewed 
result. The child/parent was requested to return the EFR within 1 month of receiving it. If the EFR 
had not been returned within this period, the researcher called to remind the parent/guardian to 
return it. The first EFR served as the baseline measurement for total daily antioxidant intake. 
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Adolescents were able to facilitate the completion of the EFR with supervised input from their 
parents, to prevent the incorrect completion. Parents/guardians were asked to provide a copy of 
the contents sheet or packaging of the VMS and/or antioxidant supplements used upon returning 
the EFR. The 24-hr recall method was used as the reference method to complement the EFR. A 
summary of the data collection process is provided in Figure 2.2.   
 
The specialist oncology paediatric dietitians on the ward assessed the each child’s nutritional 
status and provided appropriate advice on nutritional support and managing side effects of the 
treatment as per usual, without interference from the research dietitian. The nutritional support 
algorithm that was designed by these dietitians based on the available evidence for assessing 
nutritional risk, and stage at which to use a nutritional support was used in the usual way 
(Addendum J).  
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1 Estimated food record (EFR)  
 
Figure 2.2 Diagrammatical representation of data collection  
 
 
Specialist Paediatric Oncology Dietitian’s inform researcher of newly diagnosed 
patient with a Solid Tumour, Lymphoma or Leukaemia. 
Researcher approaches patient and parent/guardian to partake in study on ward or 
outpatient paediatric clinic at Addenbrookes Hospital. This occurs within first month 
of diagnosis. Written and verbal information on study provided. 
EFR1 given at first consultation and 2nd EFR2 sent in post after 3 months. 
Parent/guardian will be informed when to complete EFR1.  EFR1 completed by 
parent/guardian for 4 consecutive days (Wednesday, Thursday, Friday, Saturday). 
 
 
EFR’s1 and 24-hr recalls analyzed using Standard Manual on Food Portions and 
Household Measures in the United Kingdom and Dietplan 6.3 
 
Consent obtained from child’s/parent/guardian. Parent/guardian informed on the 
completion of EFR1 and telephone calls for 24-hr recalls.  
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2.3.1 RESEARCH TOOLS  
 
2.3.1.1 ESTIMATED FOOD RECORD  
 
No results were found upon extensive searching for a validated, 4-day EFR that specifically 
measured antioxidant intake in paediatrics. The researcher therefore developed a 4-day estimated 
food record for this purpose (Addendum H). The EFR was developed and adapted from a food 
record currently used in the Nutrition and Dietetic Department at Addenbrookes Hospital to suit the 
study’s requirements. The EFR was reviewed by two external independent reviewers. The EFR 
was adjusted to elicit appropriate information about antioxidants from a paediatric population taking 
into account oral diet, tube feeds and the use of VMS supplements. The rationale for choosing this 
specific tool in this study population was due to: 
 The traumatic experience of the diagnosis and treatment, a 4-day instead of a 7-day 
estimated food record as well as estimated food record in place of a weighted food record 
was chosen. The EFR would be less labour intensive and practical and was thought to be 
more suitable for this specific population and study.(55)  
 Data from a multiple day food record being more representative of usual/habitual intake 
than single day data from a 24-hr recall or 1-day food record.(56,57) If determining a dietary 
inadequacy or excess relative to a standard (i.e. RNI), then a single day for intake of an 
individual was not adequate in ensuring a reliable estimate of the distribution of habitual 
intake in between groups for e.g. for tube and non-tube fed children. Rutishauser and Black 
recommend that in determining distribution of habitual food intake in a group that at least 2 
days of information from each individual is needed.(58) Children’s intake on cancer treatment 
varied considerably on a daily basis due to the treatment regimes and side effects thereof. 
 The EFR not being dependent on memory as parents/guardians/children recorded foods 
and beverages at the same time of consumption.(56) 
 
The EFR was completed over 4 consecutive days (i.e. Wednesday, Thursday, Friday, and 
Saturday) in the 3rd week after discharge from hospital and again in the 3rd month of diagnosis. In 
the EFR, days were truncated into six eating occasions, namely breakfast, lunch, dinner and 
snacks (divided into morning, afternoon and evening snacks). Information on the type (including 
brand names) and amount of food consumed was collected through an open entry format. An 
example of a 1-day food intake was included to demonstrate the accurate completion of the EFR.  
Household measures such as cups, tablespoons, and teaspoons or measurements made with a 
ruler were used to quantify portion size. Items such as eggs, fruit i.e. apples, bananas or 330ml 
cans of fizzy drink were thought of as units and simply counted.  A checklist was included at the 
end of the food record booklet to help parents/guardians to check that they had completed an 
accurate record. Parents/guardians were asked to send the outer packaging, photocopy or written 
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copy of any vitamin-mineral preparations used. Parents/guardians were able to document all 
tube/sip feeds and other supplements and were prompted to specify the type of feed, volume, 
feeding hours as well as the preparation method of feed (powdered feed and concentrations). For 
children greater than 1 year, all formula, feeds, with the exact volumes needed to be documented. 
The EFR was designed to elicit information pertaining to tube/sip feeds and other supplements and 
pump feeding i.e. type of feed, volume, hours, and preparation method. Upon receiving the EFR if 
there were any parts to clarify the researcher contacted the parents/guardian.  After completion of 
the food records, these were processed by the researcher, into food gram quantities based on the 
Standard Manual on Food Portions and Household Measures in the UK.(59) 
 
2.3.1.2 24-HOUR RECALL  
 
The 24-hr recall method was introduced as a second dietary intake measurement (test method). 
This method assessed the actual intake of individuals in the study. A single 24-hr recall however 
was not sufficient to describe an individual’s usual intake of food and nutrients. Therefore to 
determine the percentage of the population ‘at risk’ of inadequate nutrient intakes, estimates of the 
usual intakes of the subjects was required. This, in turn, required that the food consumption of 
subjects was measured over more than 1 non-consecutive day. According to Gibson to achieve a 
‘level 2’ objective in determining risk, at least two independent measurements of food intake should 
have been obtained on at least a representative sub-sample of individuals in the study and on non-
consecutive days.(55) The sub-sample needed to consist of 30 to 40 individuals who represented 
the age range of the sample.(55) Once a series of replicated observations on at least 30 individuals 
were obtained, an adjustment could be made to the observed distribution of intakes to remove the 
variability introduced by day-to-day variation in nutrient intakes within an individual. The adjusted 
distribution of ‘usual’ nutrient intakes could then be used to predict the proportion of the population 
at risk of nutrient inadequacy using either the full probability approach or the RNI.(55) 
 
A standardized 24-hr recall, sourced from Weiner and Lourie cited by Gibson,(55) was used on the 
sample population to test whether the EFR was eliciting adequate information with regard to total 
daily antioxidant intake. The researcher verified the accuracy of the EFR by performing three 24-
hrrecalls by telephone the week before the EFR was completed (2nd week after discharge from 
hospital). The 24-hr recall was performed on Monday (for Sunday intake), Wednesday (for 
Tuesday intake), Friday (for Thursday intake) and Sunday (for Saturday intake) and determined the 
child’s past 24-hr intake of antioxidants. The 24-hr recall was performed on both the EFRs issued. 
The researcher was required to ask appropriate questions on the intake of foods and drinks over 
the past 24 hours using open-ended questions with no leading questions or judgemental 
comments. Telephone 24-hr recalls that were well designed and carefully administered appeared 
to be a promising and acceptable method of obtaining dietary information as described by 
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Gibson.(55) Due to the geographical location of the children it was not feasible to visit the child’s 
home to conduct the 24hr recall. 
 
2.3.2 PILOT STUDY  
 
The pilot study was tested on 4 children upon consent to the study to determine the face and 
content validity of the EFR. This process established whether meanings of the food names, portion 
size descriptions, volume and concentration of tube feeds and VMS were clearly documented in 
the EFR by the parent/guardian. It facilitated the identification of whether the instructions on how to 
complete the EFR and the EFR itself were unambiguous. Content validity was determined by 
requesting two specialist/expert paediatric Dietitians (namely Dr Anita Macdonald, Dietetic 
Manager at Birmingham Children’s Hospital, England, and Vanessa Shaw, Dietetic Manager at 
Great Ormond Street Hospital, England) to critique the EFR. Face validity was determined in the 
pilot study. The 24-hr recall was used as a reference method to complement the EFR and test 
whether the EFR was eliciting the correct information with regard to total daily antioxidant intake 
(Addendum K). Adjustments were made as necessary to the EFR based on the results from the 
pilot study. 
 
2.4 MEASUREMENT OF MALNUTRITION 
 
The tool used to measure acute malnutrition in this study was that of weight-for-age z scores.(60) 
These scores were compared to the World Health Organization definitions of malnutrition,(43) which  
uses a z-score cut-off point of <-2 SD to classify low weight-for-age, low height-for-age and low 
weight-for-height as moderate under-nutrition and severe under-nutrition as <-3 SD. Although a 
hospital protocol exists for routine growth measurements (i.e. weight, height and head 
circumference), not all of these are routinely measured by staff. In particular height is frequently not 
measured in children in the 1-3 year age group, those with vincristine induced neuropathy, those 
weak from ill health and in many children who attend weekly outpatient clinics; height isn’t 
measured weekly. Weight is seen more as a priority in the outpatient clinic to determine drug 
doses for chemotherapy. Therefore only weight was used in the study.  
 
2.5 DATA ANALYSIS 
 
Upon receiving the completed EFR and 24-hr recall data, it was manually analysed by the 
researcher into food gram quantities based on the Standard Manual on Food Portions and 
Household Measures in the United Kingdom.(59) Subsequent to this the initial analysis for the total 
intakes of antioxidants, total energy and protein were performed using the Diet Plan 6.3 
programme (Forrestfield Software Limited, Horsham, UK) (Table 2.1). 
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Table 2.1 Summary of measurements for antioxidants, energy and protein used in analysis 
Vitamin/mineral Measurement 
Vitamin A milligram (mg) α - tocopherol equivalents 
Vitamin E milligrams (mg) 
Vitamin C milligrams (mg 
Selenium microgram (ug) 
Zinc milligram (mg) 
Energy kilocalories (kcal) 
Protein gram (g) 
 
Further analysis required the use of the SPSS 16 statistical software (SPSS Science, Apache 
Software Foundation, Chicago, IL, USA). The children’s mode of feeding was divided into the 
following categories with abbreviations (Table 2.2). These dietary categories below were used to 
analyse the data in the study.  
 
Table 2.2 Mode of feeding categories and abbreviations used in study 
Mode of feeding Abbreviation 
Diet alone Diet alone 
Diet & food supplement (incl. modular 
supplements and nutritionally complete 
sip feeds) 
Diet + FS 
Diet & tube feeds Diet + tube 
Diet & multi-vitamin-mineral 
supplementation 
Diet + VMS 
Diet & multi-vitamin-mineral & food 
supplement 
Diet + FS + VMS 
 
For data analysis purposes and to meet the study’s objectives (ascertain the intake of children on 
diet + tube) the researcher grouped the diet + FS and diet + tube categories together, however 
only the children (diet + FS category) who were taking nutritionally complete sip feed supplements 
were included. These sip feeds were comparable in composition to tube feeds and could be used 
as tube feeds. The sip feeds included products such as Fortini (Nutricia), Paediasure (Abbott) and 
Paediasure Plus (Abbott) and Frebini (Fresenius) (1kcal and 1.5kcal). The children in the diet + FS 
category that were on modular supplements i.e. providing singular entities of nutrition (either fat or 
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protein or carbohydrate) were excluded from data analysis. These modular supplements included 
products such as Calogen (SHS) and Maxijul powder (SHS). The similar principle was used for the 
diet + FS + VMS category. The children in this latter category were included both into the diet + 
VMS categories. The above grouping of categories was also to ensure that the primary categories 
had sufficient numbers for statistical purposes.  
 
The child’s antioxidant intakes were compared to both the LRNI and RNI to determine adequacy. 
The RNI values are divided into the following age groups i.e. 1-3, 4-6, 7-10, 11-14, and 15-18 
years of age, which were also used for the analysis of this dietary data. In the case whereby 
children fell between the above age group ranges, their antioxidant intake was compared to the 
age group rounded to the closest ten-decimal. Similarly the protein and energy intake was 
compared to the EAR (Addendum C). The adequacy of intake was measured in percentage by 
measuring the actual intake to the RNI requirement for the age and gender of that child. Dietary 
adequacy was assumed at 100% and above of the RNI for the antioxidant. As it was possible for 
children to exceed this threshold a further parameter of greater than and equal to 200% was set. 
Similarly the actual intakes were compared to the LRNI. If the child’s intake was below the LRNI, 
then it was assumed that the intake was inadequate and that the child may be deficient in that 
vitamin or mineral. If a child’s habitual intake was less than and below the LRNI it was likely that 
the individual would not be consuming enough of the nutrient to maintain appropriate parameters 
of nutritional status for that nutrient, and further investigations, including biological measures may 
be appropriate.(16) 
 
The Chi-square test was used to test for the differences between the three feeding modes intakes 
of antioxidants, energy and protein in the 1st and 3rd month (significance level at p<0.05). To 
measure significant changes in the antioxidant, protein and energy intake between month 1 and 
month 3, the Fishers Exact Test was used (significance level at p<0.05). The Shapiro-Wilk formula 
was used to assess the normality of the distribution of data between the EFR and the 
corresponding 24-hr recall. Both the Shapiro-Wilk and Fishers Exact Test was used due to the 
smaller analysis categories. Bivariate correlation (Spearman and Pearson) were used to determine 
the strength and direction of the relationship between the EFR and corresponding 24-hr recall.  In 
addition, t-tests were used to compare the mean score of nutrient intakes, based on the EFR and 
24-hr recall, between the two groups.   
 
Descriptive data was presented as means, medians and standard deviations. Results were 
deemed significant if the p–value was less than 0.05.The deviation from the daily RNI was 
determined for each child making use of diet, diet with tube feeding and diet with VMS and was 
presented in percentage deviation. The antioxidant, energy and protein intake for the EFR in the 
first month was compared to that obtained in the 3rd month to determine changes in the intake of 
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energy, protein, and antioxidants as treatment progressed. The percentage of children meeting 
their RNI requirement as well as those consuming double this requirement for antioxidants, EAR 
protein and energy were documented. The vitamin and/or mineral supplements were divided into 
two main groups namely those providing a full complement of vitamins and minerals and those that 
primarily provided vitamins. 
 
Each child’s nutritional risk which was based on their type and stage of cancer was determined by 
the criteria set out by Rickard et al.(41) and cited by Ward (Table 1.2). Acute malnutrition was 
measured by means of documenting each child’s weight at the 1st and 3rd month. This data was 
then entered into the Anthro. Epi InfoTM Version 3.3.2 (CDC, USA) programme which determined z-
scores for weight-for-age. To prevent the use of two data analysis programmes the Anthro. Epi 
InfoTM programme was used instead of the WHO database. The rationale for this was that the 
Anthro Epi InfoTM programme was able to determine the z-scores of the study population that 
included children of 1-16 years of age, whereas the WHO anthropometry database only measured 
z-scores of children less than 5 years of age. The weight-for-age z-scores as well as the mean and 
standard deviation (SD) z-scores were then assessed against the World Health Organization 
Global Database on Child Growth and Malnutrition.(43) The children nutritional risk was assessed 
according to associated types of childhood cancers that were set out in Table 1.2. 
 
2.6 ETHICS APPROVAL 
 
The NHS as well as Stellenbosch University required ethical approval for this study. Approval was 
therefore obtained from the Health Research Committee of Stellenbosch University (South Africa) 
(Ethics Reference Code N08/04/094) (Addendum L) and Hertfordshire Research Ethics Committee 
(England) (Ethics Reference Code 08/H0311/53) and R & D Department at Addenbrookes Hospital 
(Addendum M).   
 
Parents/guardians and children were provided with all appropriate documentation to consider the 
study as outlined in section 2.3. It was required that prior to obtaining consent that parents were 
informed of the following: 
 Patient confidentiality would be adhered to at all times. 
 Withdrawal from the study was allowed at any point in time, and this wouldn’t affect further 
treatment plan. It was agreed upon ethics approval that if data was collected and the child 
withdrew that any valuable data that could contribute to the antioxidant intake data would 
be retained and used towards the study. Children/parents/guardians would be made aware 
that anonymous data would be sent to South Africa for consultation by the statistician. 
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 If the intakes of antioxidants, energy and protein were deficient that the 
child/parent/guardian would be informed and be provided with appropriate advice to correct 
this. 
 
The parent/guardian signed the consent form for the child or adolescent partaking less than 16 
years of age. If a child was over 7 years of age they were allowed to sign the ascent form or the 
consent form for the parent. This was stipulated by the local Health Trust specifications. The 
original copy of the consent form was kept with the researcher in a file locked in the Nutrition and 
Dietetic Department, at Addenbrookes Hospital. A copy was placed in the child’s medical notes 
and the parent/guardian was also provided with a copy (Addendum G). Upon study completion the 
data will be stored for 5 years by the Study Supervisor and Paediatric Haematology Department of 
Addenbrookes Hospital for 15 years as required by National Ethics Research Service (England). 
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CHAPTER 3 RESULTS 
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3.1 DESCRIPTION OF STUDY 
 
3.1.1 MAIN STUDY RESULTS 
 
3.1.1.1 PATIENT DEMOGRAPHICS 
 
The collated data of forty-two children (male n=20; female n=22) was used for analysis in this study 
(Table 3.1). The mean age was 7 years 6 months (SD 4.8), with an age range of 12 months to 15.5 
years. Fifty two children were recruited to this study over a period of 1 year and 8 months; however 
10 children were not included in the data analysis for the following reasons; 4 (8%) withdrew from 
study; 1 (2%) was not discharged from hospital during treatment; 1 (2%) transferred to an out of 
area hospital; 4 (8%) consented to study, but did not respond to requests for data. Of the 42 
children’s data that was analysed, a large proportion returned their EFR’s in the 1st month’s 
collection of data (n=30; 71%). However the return rate of EFR’s in the 3rd month was less than the 
1st month (n=22; 52%). Reasons for this as reported by parents were: EFR’s were lost in the post 
and that parents did not have time to complete the EFR due to busy treatment schedules and 
home life. The demographics of the study population are outlined in Table 3.1. Children were 
categorised into the following diagnosis groups: Leukaemia (n=14; 33%), Lymphoma (n=10; 24%), 
and Solid tumours (n=18; 43%).  
 
Table 3.1: Demographic data and characteristics of the children recruited to the study 
 
All Male Female 
Number of children [n;(%)] 42 20 (48%) 22 (52%) 
Age groups [n;(%)] 
1-3 years 
4-6years 
7-10years 
11-14years 
15-18years 
 
13 (31%) 
9 (21%) 
6 (15 %) 
13 (31%) 
1 (2%) 
 
4 (10%) 
6 (14%) 
4 (10%) 
6 (14%) 
0 (0%) 
 
9 (21%) 
3 (7%) 
2 (5%) 
7 (17%) 
1 (2%) 
Mean age of children 
Standard deviation 
Age Range 
7 years 6 months 
 
SD 4.8 
1–15.5 years 
7 years 7 months 
 
SD 4.28 
1.6-14.5 years 
7 years 2 months 
 
SD 5.39 
1-15.5 years 
 
Therapy modalities were categorised into chemotherapy and combination chemo- and 
radiotherapy. Twenty eight (67%) of the children underwent chemotherapy and fourteen (33%) a 
combination of therapies. For data analysis purposes and to meet the study objectives the 
researcher grouped the diet + FS (1st month n=11; 3rd month n=5) and diet + tube categories (1st 
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month n=2; 3rd month n=3) together.  The child’s mode of feeding as categorised for this study is 
represented for the 1st month in Table 3.2 and 3rd month in Table 3.3.  
 
Table 3.2 Mode of feeding for estimated food record and 24-hr recall (1st month) 
Mode of feeding 
 
Nr. completed 
EFR 
% from 
EFR 
Nr. completed  
24-hr recall 
% from 
24-hr recall 
Diet only 11 26 15 36 
Diet + tube 11 26 11 26 
Diet + FS 3 7 5 12 
Diet + VMS 6 14 9 21 
Diet + FS + VMS 2 5 2 5 
Data not completed 9 21 0 0 
  
EFR = estimated food record                                       FS = food supplement 
VMS = multi - vitamin-mineral supplement                  Data not completed = child/parent did not return data 
 
 
Table 3.3 Mode of feeding for estimated food record and 24-hr recall (3rd month) 
 
Mode of feeding Nr. completed  
EFR 
% from 
EFR 
Nr completed 
24-hr recall  
% from 
24-hr recall  
Diet only 10 24 13 31 
Diet + tube 5 12 10 24 
Diet + FS 3 7 3 7 
Diet + VMS 4 9 5 12 
Diet + FS + VMS 0 0 1 2 
Data not completed 20 48 10 24 
 
EFR = estimated food record                                      FS = food supplement 
VMS = multi - vitamin-mineral supplement                 Data not completed = child/parent did not return data 
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3.1.1.2. NUTRITIONAL STATUS 
 
Each child’s nutritional risk was determined by assessing their type and stage of cancer as set out 
by the criteria by Rickard et al.(41) and cited by Ward (Table 1.2).(42)  The latter nutritional risk was 
summarised in Table 3.4 and showed that 95% (n=40) of the children were seen as at high 
nutritional risk and 5% (n=2) at low risk. 
 
Malnutrition was assessed using the weight-for-age scores and comparing it to the criteria set out 
by the WHO for malnutrition, as described in the methodology.(43) Malnutrition as determined with 
this methodology is presented in Figure 3.1 for the 1st and 3rd month.  In the 1st and 3rd month, 39 of 
the children had a weight and a height (when available) documented. A mean z-score for the study 
population was calculated at the 1st (-0.22) and 3rd (-0.34) month. This indicated that the study 
population on the whole were well-nourished. The WHO malnutrition criteria states that if the mean 
score is significantly lower than zero it suggests that most of the individuals in the population have 
been affected by malnutrition. Ninety five percent (n=37) of the children z-scores for weight-for-age 
were within the normal range in the 1st month and 85% (n=33) in the 3rd month. In the 1st month, 
5% (n=2) of the children achieved a z-score of <-2 and 10% (n=4) in the 3rd month (both months 
depicting moderate malnutrition). There was no statistical difference seen between the number of 
children presenting with moderate malnutrition between the 1st and 3rd month (p=0.67; Fishers 
Exact Test). In the 1st and 3rd month the Solid tumour and Leukaemia group each had 1 (3%) child 
with a z-score of <-2 and likewise in the 3rd month. The lymphoma group only presented with 1 
(3%) child in the 3rd month with a z-score of <-2. Children in the Leukaemia group were the only to 
present in the overweight (n=1; 3%) and obese (n=3; 3%) category in both the 1st and 3rd month. 
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Table 3.4 Summary of types of childhood cancers associated with nutritional risk based on  
      guidance provided by Rickard et al.(41,42)  
Diagnosis Nutritional Risk(41, 42) 
 
Diagnosis Frequency % 
High 
risk 
% 
Low 
Risk 
% 
Acute promyelocytic leukaemia 1 2.4 √    
Acute lymphoblastic leukaemia 
(Reg A) 1 2.4  
 √  
 
Acute lymphoblastic leukaemia 
(Reg B) 11 26.2 √ 
 
 
 
B - cell non hodgkins 
lymphoma 4 9.5 √ 
 
 
 
Burkitts lymphoma 2 4.8 √    
Ewings sarcoma 1 2.4 √    
Germ cell tumour and 
metastasis 1 2.4 √ 
 
 
 
Medulloblastoma 2 4.8 √    
Medulloblastoma and 
metastasis 1 2.4 √ 
 
 
 
Neuroblastoma (stage III) 1 2.4 √    
Neuroblastoma (Stage IV) 2 4.8 √    
Osteosarcoma 1 2.4 √    
Osteosarcoma and metastasis 1 2.4 √    
Relapse wilms tumour 1 2.4 √    
Rhabdomyosarcoma 2 4.8 √    
Rhabdomyosarcoma and 
metastasis 1 2.4 √ 
 
 
 
T - cell lymphoblastic 
leukaemia 1 2.4 √ 
 
 
 
T - cell lymphoblastic 
lymphoma 1 2.4 √ 
 
 
 
T - cell non hodgkins 
lymphoma 3 7.1 √ 
 
 
 
Unilateral retinoblastoma 1 2.4   √  
Wilms tumour (Stage III) 2 4.8 √    
Wilms tumour (Stage IV) 1 2.4 √    
 
Total 
 
42 
 
100.0 
 
40 
 
95% 
 
2 
 
5% 
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Figure 3.1   Grouping of z-scores for weight-for-age at initial assessment (1st month) and follow up (3rd month) 
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Figure 3.2  Malnutrition z-scores for children with Solid tumours, Lymphomas and Leukaemia at initial assessment (1st month) and follow up 
(3rd month) 
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3.1.1.3 VALIDITY OF DIETARY INTAKE METHODS 
 
3.1.1.3.1 CORRELATION OF DIETARY INTAKE TOOLS FOR ANTIOXIDANT INTAKE 
 
The repeated 24-hr recalls were used to correlate against the EFR to determine if the EFR was 
eliciting accurate information. The following vitamin and mineral intakes from the EFR and 24-hr 
recall correlated highly in the 1st month (EFR1); vitamin A (diet alone; p=0.00; r=0.70), vitamin C 
(diet alone; p=0.00; r=0.56), vitamin E (diet alone; p=0.00; r=0.54), selenium (diet alone; p=0.00; r 
=0.64) and zinc (diet alone; p=0.00; r=0.81). In the 3rd month (EFR”) the following correlated highly; 
vitamin A (diet alone; p=0.00; r=0.70), vitamin C (diet alone; p=<0.05; r=0.72), vitamin E (diet 
alone; p=0.05; r=0.45), and selenium (diet alone; p=0.00; r=0.61) (Table 5). Therefore for all the 
antioxidants in the diet alone category significant correlations were seen between the EFR and   
24-hr recall. There were too few children in the category of diet + VMS (n=8 1st month; n=4 3rd 
month) to reach statistical significance or meaningful interpretation and no correlation was seen for 
the diet + tube category (n=13, 1st month; n=8, 3rd month). On closer inspection it was found that 
parents varied tube feed intake significantly from day to day. This was highly dependent on their 
child’s toleration of oral intake and/or tube feeds during and post chemotherapy and radiotherapy 
sessions. Flexible tube feeding regimes were provided by the Dietitian to accommodate for the 
child’s oral intake (retain normality of eating patterns), the need for additional top-ups of feed or 
weaning down of feed to improve tolerance.  These factors would explain the poorer correlation in 
the diet + tube category. As the EFR and the repeated 24-hr recall were highly correlated for the 
majority of categories for protein and energy with significant numbers of children and as it 
represented four days of continuous dietary intake instead of non-consecutive days, further 
analysis was based on the EFR. 
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Table 3.5:  Correlation of the estimated food record and 24-hr recalls for mode of feeding and    
                        Antioxidants (1st and 3rd month) 
Antioxidants r - value 
Strength of relationship 
Small (r =0.10-0.29) 
Medium( r= 0.30-0.49) 
Large ( r= 0.50-1.0) 
p- value 
 
Significant 
 
Vitamin A 
EFR 11  & 24-hr recall 1 
Diet alone 
Diet + tube 
Diet + VMS2 
EFR 21 & 24-hr recall 2 
Diet alone 
Diet + tube 
Diet + VMS2 
 
 
0.70 
-0.07 
0.70 
 
0.70 
0.61 
0.50 
 
 
large 
small 
large 
 
large 
large 
large 
 
 
0.00 
0.83 
0.19 
 
0.00 
0.15 
0.67 
 
 
          ▲ 
 
 
 
* 
Vitamin C 
EFR 11 & 24-hr recall 1 
Diet alone 
Diet  + tube 
Diet + VMS2 
EFR 21 & 24-hr recall 2 
Diet alone 
Diet + tube 
Diet + VMS2 
 
 
0.56 
0.65 
0.00 
 
0.72 
0.38 
0.50 
 
 
large 
large 
- 
 
large 
medium 
large 
 
 
0.00 
0.08 
1 
 
0.00 
0.35 
0.67 
 
 
* 
 
~ 
 
* 
 
Vitamin E 
EFR 11 & 24-hr recall 1 
Diet alone 
Diet  + tube 
Diet + VMS2 
EFR 21 & 24-hr recall 2 
Diet alone 
Diet + tube 
Diet + VMS2 
 
 
0.54 
0.39 
1 
 
0.45 
0.50 
1 
 
 
large 
medium 
large 
 
medium 
large 
large 
 
 
0.00 
0.38 
-0.99 
 
0.05 
0.17 
-0.99 
 
 
* 
 
 
 
* 
Selenium 
EFR 11 & 24-hr recall 1 
Diet alone 
Diet  + tube 
Diet + VMS2 
EFR 21 & 24-hr recall 2 
Diet alone 
Diet + tube 
Diet + VMS2 
 
 
0.64 
0.10 
1 
 
0.61 
-0.02 
0.50 
 
 
large 
small 
large 
 
large 
small 
large 
 
 
0.00 
0.80 
-0.99 
 
0.00 
0.96 
0.67 
 
 
* 
 
 
 
* 
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Antioxidants r - value 
Strength of relationship 
Small (r =0.10-0.29) 
Medium( r= 0.30-0.49) 
Large ( r= 0.50-1.0) 
p- value 
 
Significant 
 
Zinc 
EFR 11 & 24-hr recall 1 
Diet alone 
Diet  + tube 
Diet + VMS2 
EFR 21 & 24-hr recall 2 
Diet alone 
Diet + tube 
Diet + VMS2 
 
 
0.81 
0.45 
1 
 
0.38 
0.02 
-0.99 
 
 
large 
medium 
large 
 
medium 
medium 
large 
 
 
0.00 
0.26 
-0.99 
 
0.10 
0.96 
-0.99 
 
 
 
▲ 
 
 
 
 
 
 
 
 
1
   EFR = estimated food record                                            2  VMS = multi - vitamin-mineral supplement 
 *  Correlation is significant at the p<0.05 level                   ▲Correlation is significant at the p<0.01 level  
 ~  Perfect positive correlation – if one variable increases so will the other 
 
3.1.1.3.2 CORRELATION OF DIETARY TOOLS FOR ENERGY AND PROTEIN INTAKE 
  
Similar results with highly statistical correlation were seen between EFR and 24-hr recalls with the 
diet alone mode of feeding when looking at protein and energy intake in Table 3.6. The following 
variables that were highly correlated in the 1st month (EFR1) were; energy (diet alone; p= 0.00; 
r=0.85), energy (diet alone; p=0.00; r=0.77) and protein (diet alone; p=<0.05; r=0.79). A further 
correlation was seen in the 3rd month (EFR2) for protein (diet alone; p=<0.01; r=0.54). Once again 
the diet + tube group did not correlate well between the EFR and 24-hr recall. On closer inspection 
it was found that parents varied tube feed intake significantly from day to day. This was highly 
dependent on their child’s toleration of oral intake and/or tube feeds during and post chemotherapy 
and radiotherapy sessions. Flexible tube feeding regimes were provided by the Dietitian to 
accommodate for the child’s oral intake (retain normality of eating patterns), the need for additional 
top-ups of feed or weaning down of feed to improve tolerance.  These factors would explain the 
poorer correlation in the diet + tube category. As the EFR and the repeated 24-hr recall were highly 
correlated for the majority of categories for protein and energy with significant numbers of children 
and as it represented four days of continuous dietary intake instead of non-consecutive days, 
further analysis was based on the EFR. 
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Table 3.6  Correlation of the EFR and 24-hr recalls for mode of feeding and energy and protein 
intake (1st and 3rd months) 
Energy (kcal) r - 
value 
Strength 
Small (r =0.10-0.29) 
Medium( r= 0.30-0.49) 
Large ( r= 0.50-1.0) 
 
p- value 
 
 
Significant 
 
 
EFR11 & 24-hr recall 1 
(Energy) 
Diet alone 
Diet + tube 
 
 
0.85 
0.77 
 
 
large 
large 
 
 
0.00 
0.00 
 
 
* 
* 
EFR 11 & 24-hr 1 recall 
(Protein) 
Diet alone 
Diet  + tube 
 
 
0.79 
0.30 
 
 
large 
medium 
 
 
0.00 
0.37 
 
 
* 
EFR 21 & 24-hr recall 2 
(Energy) 
Diet alone 
Diet + tube 
 
 
0.29 
0.21 
 
 
small 
small 
 
 
0.21 
0.64 
 
EFR 21 & 24-hr recall 2   
(Protein) 
Diet alone 
Diet + tube 
 
 
0.54 
0.36 
 
 
large 
medium 
 
 
0.01 
0.43 
 
 
* 
 
1  EFR = estimated food record 
* Statistical significance determined at p<0.05  
 
3.1.1.4  COMPARISON OF ANTIOXIDANT INTAKES WITH DIETARY REFERENCE VALUES 
AND SAFE INTAKES 
 
3.1.1.4.1 RECOMMENDED NUTRIENT INTAKE AND SAFE INTAKE FOR ANTIOXIDANTS 
 
The intakes of vitamin A, C, selenium and zinc were compared to each child’s age appropriate RNI 
(Addendum N) and LRNI values (Addendum O). Children achieving greater than 100% and 200% 
of their RNI for each antioxidant are shown in Table 3.7.  
The Chi-square test was used to ascertain a statistical difference in the number of children 
achieving their RNI’s between the 3 modes of feeding in the 1st month and 3rd month (Table 3.7 
and 3.8). In both the 1st and 3rd month there was a greater number of children achieving ≥ 100% 
RNI for vitamin A for diet + VMS (EFR1; p=0.00; EFR2; p=0.00) than the other feeding modes. The 
greatest number of children achieving ≥ 200% of RNI in the 3rd month was for vitamin E (diet + 
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tube; p=0.01) and vitamin C (diet + VMS; p=0.01). There was not a significant difference in 
selenium and zinc intake between the modes of feeding in the 1st and 3rd month (p - values ranging 
from 0.1 to 0.47).  
 
Differences in antioxidant intake (≥ 100% and ≥ 200%) between the 1st and 3rd month were 
determined by means of the Exact Fisher test. There was no statistical difference seen between 
the number of children achieving their RNI for antioxidant intake between the 1st and 3rd month 
(Table 3.7 and 3.9). Of all the antioxidants, vitamin C achieved the highest intakes compared to the 
RNI (EFR1: diet + VMS; 773% and EFR2: diet + tube: 829%) (For further information see 
Addendum N).  
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Table 3.7:  Percentage of children achieving ≥100% and 200% of Recommended Nutrient Intake for antioxidants 
EFR 11 
1st month 
EFR 21 
3nd month 
 
 
Diet 
≥100% 
 
Diet 
≥200% 
Diet + 
tube 
≥100% 
Diet + 
tube 
≥200% 
Diet + 
VMS2 
≥100% 
Diet + 
VMS2 
≥ 200% 
 
Diet 
≥100% 
 
Diet 
≥200% 
Diet + 
tube 
≥100% 
Diet + 
tube 
≥200% 
Diet + 
VMS2 
≥100% 
Diet + 
VMS2 
≥ 200% 
Vitamin A 9% (1/11) 
0% 
(0/11) 
46% 
(6/13) 
8% 
(1/13) 
100% * 
(8/8) 
25% 
(2/8) 
0% 
(0/10) 
0% 
(0/10) 
50% 
(4/8) 
13% 
(1/8) 
   75%* 
(3/4) 
25% 
(1/4) 
Vitamin C 82% (9/11) 
64% 
(7/11) 
77% 
(10/13) 
69% 
(9/13) 
100% 
(8/8) 
88% 
(7/8) 
70% 
(7/10) 
20% 
(2/10) 
88% 
(7/8) 
63% 
(5/8) 
100% 
(4/4) 
   100%* 
(4/4) 
Vitamin E~ 55% (6/11) 
18% 
(2/11) 
77% 
(10/13) 
38% 
(5/13) 
88%  
(7/8) 
63% 
(5/8) 
50% 
( 5/10) 
0% 
(0/10) 
88% 
(7/8) 
   63%* 
(5/8) 
  100%* 
(4/4) 
50% 
(2/4) 
Selenium 36% (4/11) 
0% 
(0/11) 
69% 
(9/13) 
8% 
(1/13) 
43% 
(3/7) 
14% 
(1/7) 
20% 
(2/10) 
0% 
(0/10) 
63% 
(5/8) 
25% 
(2/8) 
50% 
(1/2) 
0% 
(0/2) 
Zinc 36% (4/11) 
0% 
(0/11) 
77% 
(10/13) 
8% 
(1/13) 
43% 
(3/7) 
29% 
(2/7) 
20% 
(2/10) 
0% 
(0/10) 
63% 
(5/8) 
25% 
(2/8) 
50% 
(1/2) 
50% 
(1/2) 
  
1
  EFR = estimated food record                                      2 VMS = multi - vitamin-mineral supplement 
 ( ) Brackets show number of children in that particular mode of feeding achieving ≥ 100% or ≥200% of Recommended Nutrient Intake(61) 
 ~ Vitamin E is measured as a safe intake, no Recommended Nutrient Intake available 
*    This particular feeding mode had a statistically greater number of children achieving less than the lower recommended nutrient intake compared to the other 
feeding modes in that month   
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Table 3.8: Chi-square Test comparing children achieving Recommended Nutrient Intakes between feeding modes in the 1st and 3rd Month (p-value) 
EFR 11 
1st month 
EFR 21 
3rd month 
 Diet / Diet + tube / Diet + 
VMS2 
(≥100%) 
Diet / Diet + tube / Diet + 
VMS2 
(≥200%) 
Diet / Diet + tube / Diet + 
VMS2 
(≥100%) 
Diet / Diet + tube / Diet + 
VMS2 
(≥200%) 
Vitamin A 
  0.00* 0.17   0.00* 0.31 
Vitamin C 0.35 0.50 0.36 
  0.01* 
Vitamin E 0.25 0.14 0.08 
  0.01* 
Selenium 0.23 0.47 0.17 0.18 
Zinc 0.10 0.12 0.17 0.11 
 
1
  EFR = estimated food record                                      2 VMS = multi - vitamin-mineral supplement  
*Significance at p<0.05       
 
Table 3.9: Fisher Exact Test comparing children achieving Recommended Nutrient Intakes between the 1st and 3rd month for each                                               
                  Feeding mode (p-value)       
 
 
 
Diet 
(≥100%) 
 
Diet  
(≥200%) 
 
Diet + tube 
(≥100%) 
 
Diet + tube 
(≥200%) 
 
Diet + VMS2 
(≥100%) 
 
Diet + VMS2 
(≥ 200%) 
Vitamin A 0.99 0.99 0.99 0.99 0.33 0.99 
Vitamin C 0.63 0.08 0.99 0.99 0.99 0.99 
Vitamin E 0.99 0.47 0.99 0.38 0.99 0.99 
Selenium 0.63 0.99 0.99 0.53 0.99 0.99 
Zinc 0.63 0.99 0.63 0.53 0.99 0.41 
 
 
1
  VMS = multi - vitamin-mineral supplement  *Significance at p<0.05  
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3.1.1.4.2 LOWER RECOMMENDED INTAKE FOR ANTIOXIDANTS 
 
The number of children achieving lower than and equal to 100% of their LRNI between the 3 
modes of feeding in the 1st and 3rd month are shown in Tables 3.10 and 3.11 and statistical 
significance was established using the Chi-square test. It showed that the least number of children 
to meet the LRNI for any antioxidant were in the diet alone group for vitamin A (EFR1; ≤100%; diet 
alone; p=0.00) and zinc (EFR1; ≤100%; diet alone; p=0.02) in the 1st month. For all three feeding 
modes in the 3rd month children were achieving vitamin C intakes greater than the LRNI (EFR2; 
≤100%; diet alone; diet + tube and Diet + VMS; p=0.00). There was no significant difference seen 
in children achieving their LRNI for antioxidant intake (≤100%) between the 1st and 3rd month 
(Table 3.12).   
 
Table 3.10:  Percentage of children achieving ≤ 100% of the Lower Recommended Nutrient Intake  
                    for antioxidants 
EFR 11 
1st month 
EFR 21 
3nd month 
 
 
Diet 
(≤100%) 
 
Diet + tube 
(≤100%) 
Diet + 
VMS2 
(≤100%) 
 
Diet 
(≤100%) 
 
Diet + tube 
(≤100%) 
Diet + 
VMS2 
(≤100%) 
Vitamin A 45%* (5/11) 
0% 
(0/13) 
0% 
(0/8) 
50% 
(5/10) 
25%  
(2/8) 
0% 
(0/4) 
Vitamin C 9% (1/11) 
0% 
(0/13) 
0%  
(0/8) 
0%* 
(0/10) 
 0%* 
(0/8) 
0%* 
(0/4) 
Selenium 9% (1/11) 
0% 
(0/13) 
29% 
(2/7) 
30% 
(3/10) 
0% 
(0/8) 
0% 
(0/2) 
Zinc 45%* (5/11) 
0% 
(0/13) 
29%  
(2/7) 
50%* 
(5/10) 
0% 
(0/8) 
0% 
(0/2) 
 
1
  EFR = estimated food record                                      2 VMS = multi - vitamin-mineral supplement 
 ( )  Brackets show fraction of children in that particular mode of feeding achieving ≤ 100% of Lower   
     recommended nutrient intake (61) 
* This particular feeding mode had a statistically greater number of children achieving less than the lower 
recommended nutrient intake compared to the other feeding modes in that month   
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Table 3.11: Chi-square Test comparing children achieving Lower Recommended Nutrient Intake   
   
                    between feeding modes in 1st and 3rd month (p-value) 
EFR 11 
1st month 
EFR 21 
3nd month 
 
Diet / Diet + tube / Diet + VMS2 
(≤100%) 
Diet / Diet + tube / Diet + VMS2 
(≤100%) 
Vitamin A   0.00 * 0.16 
Vitamin C 0.37   0.00 * 
Selenium 0.11 0.17 
Zinc   0.02 * 0.35  
1
  EFR = estimated food record                                      2 VMS = multi - vitamin-mineral supplement 
*Significance at p<0.05 (Chi-square test)* 
 
Table 3.12: Fisher Exact Test comparing children achieving Lower Recommended Nutrient Intake   
                    between the 1st and 3rd month for each feeding mode (p-value)           
 
 
 
 
 
 
 
 
 
 
 
 
1  VMS = multi vitamin-mineral supplement 
 
 
3.1.1.4.3  COMPARISON OF ENERGY AND PROTEIN INTAKES TO ESTIMATED AVERAGE 
REQUIREMENTS 
 
The protein and energy requirement of each child was compared to the EAR as appropriate for the 
child’s age (Addendum P). The number of children achieving greater than 100% and 200% of their 
EAR for protein and energy are shown in Table 3.13. The Fisher Exact test showed no statistical 
difference between the number of children attaining their EAR’s between the 3 modes of feeding in 
the 1st month and 3rd month (see Table 3.14). No statistical significance between the modes of 
feeding in the 1st month and 3rd month was seen. Similarly there was no significant change seen in 
children achieving their EAR for energy and protein between the 1st and 3rd month (≥100%) (Table 
3.15).  
 
 Diet (≤100%) Diet + tube (≤100%) Diet + VMS1 (≥200%) 
Vitamin A 0.99 0.13 0.99 
Vitamin C 0.99 0.99 0.99 
Selenium 0.31 0.99 0.99 
Zinc 0.99 0.99 0.99 
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Table 3.13: Percentage of children achieving greater than 100% and 200% of Estimated Average  
                    Requirement for energy and protein 
 
EFR 11 
1st month 
EFR 21 
3nd month 
 
Diet 
≥100% 
Diet 
≥200% 
Diet + 
tube 
≥100% 
Diet + 
tube 
≥200% 
Diet 
≥100% 
Diet 
≥200% 
Diet + 
tube 
≥100% 
Diet + 
tube 
≥200% 
Energy 27% (3/11) 
0% 
(0/11) 
43% 
(6/14) 
0% 
(0/14) 
10% 
(1/10) 
0% 
(0/10) 
38% 
(3/8) 
0% 
(0/8) 
Protein 91% (10/11) 
73% 
(8/11) 
100% 
(14/14) 
64% 
(9/14) 
80% 
(8/10) 
40% 
(4/10) 
100% 
(8/8) 
63% 
(5/8) 
 
1 EFR = estimated food record 
( ) Brackets show fraction of children in that particular mode of feeding achieving ≥100% or ≥200% of 
Estimated Average Requirement 
 
Table 3.14 Chi-square Test comparing children achieving Estimated Average Requirement 
                   between feeding modes in 1st and 3rd months (p-value) 
 
EFR 11 
1st month 
EFR 21 
3nd month 
 
Diet / Diet + tube / 
Diet + VMS2 
(≥100%) 
Diet / Diet + tube / 
Diet + VMS2 
(≥200%) 
Diet / Diet + tube / 
Diet + VMS2 
(≥100%) 
Diet / Diet + tube 
/ Diet + VMS2 
(≥200%) 
Energy 0.99 0.99 0.25 0.99 
Protein 0.44 0.50 0.07 0.66 
 
1
  EFR = estimated food record                                      2 VMS = multi - vitamin-mineral supplement 
 
Table 3.15  Fisher Exact Test comparing children achieving Estimated Average Requirement 
between the 1st and 3rd month for each feeding mode in the Estimated Food Record 
(p-value) 
 
 
   
Diet (≥100%) 
  
   Diet (≥200%) 
 
Diet + tube (≥100%) 
 
Diet + tube (≥200%) 
Energy 0.59 0.99 0.99 0.99 
Protein 0.59 0.20 0.99 0.99 
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3.1.1.5 FAT-SOLUBLE VITAMINS (A and E) AND SAFE UPPER INTAKES 
 
The vitamin A and E intakes were compared against the Safe Upper Intake advised by and cited 
by the DOH (UK) (Addendum D).(16) Neither the Vitamin A or E exceeded the Safe Upper Intakes 
despite the use of tube feeding (including food supplements) and vitamin and/or mineral 
supplements (For further information see Addendum N). 
 
3.1.1.6 PREVALENCE AND TYPE OF VITAMIN-AND/OR MINERAL SUPPLEMENT USE 
 
Of the children who returned their EFR in the 1st month, 27% (n=8) consumed vitamin and/or 
mineral supplements and 18% (n=4) in the 3rd month. The vitamin and/or mineral supplements 
were further divided into two categories namely vitamin supplement (VS) and multi vitamin-mineral 
supplement (MVMS) (Table 3.16). More children consumed vitamin supplements (n=5; 63%) 
compared to multi-vitamin-mineral supplements (n=3; 24%) in the 1st month. However the use of 
both VS and MVMS decreased between the 1st and 3rd month. In general the types of vitamins and 
mineral supplements used in the sample population were: MVMS - Wellkids soft and chewable 
(n=1; 2%); Sanatogen A-Z children (n=1; 2%), Adult Tesco A-Z multivitamin-mineral (n=1; 2%), My 
First Flintstones (n=1; 2%) and for VS: Dalivit (n=1; 2%), Bassetts soft and chewy pastilles, ASDA 
Great Stuff chewy pastilles (n=2; 5%), Kia Ora Real Fruit Pastilles (n=1; 2%) and Seven Seas 
vitamin and mineral tonic (n=1; 2%).  
 
Table 3.16 Frequency of use of multivitamin-mineral and vitamin based supplements in Estimated  
                  Food Records 
       1st month        3rd month 
MVMS1 
3/8 
(24%) 
2/4 
(50%) 
VS2 
5/8 
(63%) 
2/4 
(50%) 
 
1 MVMS – multi vitamin-mineral supplement 
2
 VS – vitamin supplement  
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CHAPTER 4 DISCUSSION 
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4.1 INITIAL OBSERVATIONS 
 
This prospective analysis of forty two children with cancer suggested a vulnerability to antioxidant, 
and energy depletion in certain modes of feeding. Few published paediatric studies exist analysing 
the dietary antioxidant, energy and protein intake of children with cancer, especially in determining 
the threshold at which the antioxidant intakes could interfere with cancer treatment or decrease the 
side effects during treatment.  
 
4.2 OUTCOMES 
 
4.2.1 ASSESSMENT OF DIETARY INTAKE 
 
This study relied on both EFR and repeated 24-hr dietary recalls (test method) to establish dietary 
intake. Both methods have well established strengths and weaknesses. The strengths of the 24h 
recall include; inexpensive and quick to administer, provides detailed information on specific foods 
and requires a low effort by participants thus supported well. Conversely the 24-hr recall is limiting 
in that subjects can withhold or alter information on what they have eaten due to poor memory, 
embarrassment or to please the researcher. However the primary limitation of the 24-hr recall is 
that data from a single-days diet could be a poor descriptor of an individual’s usual nutrient intake 
due to intra-individual or day-to-day variability.(56) Strengths of the EFR include; no reliance on 
memory as meals/snacks and beverages were documented at the time of eating. Multiple day data 
is also more representative of usual intake than one 24-hr recall or a 1-day food record. Therefore 
the 24-hr recall and EFR complement each other in extracting information. The limitations in this 
study were that respondents needed to be literate and be willing to give the time and effort.(56) As 
there was no standardised or validated EFR available in English that could elicit antioxidant intake 
in children, an EFR was developed and assessed prior to use.  
 
These dietary methods were tested in the pilot study that included four children, all of which were 
incorporated into the main study data. The main functions of the pilot study were to test the 
adequacy of the research tools, assess the feasibility for the study, establish whether the technique 
was effective, identify logistical problems with recruitment, and variability in outcomes to help 
determine sample size.(62) There is however limitations to pilot studies in that they do provide some 
indication to the likely sample size of the main study, but cannot guarantee this; due to being 
based on small numbers. A further limitation is the contamination of data that can occur if pilot 
study data is incorporated into main study data.(62) This usually occurs if significant modifications 
are made to the research tools.(62) The researcher for this study chose to incorporate the pilot data 
into the main study. This decision was taken due to only minor amendments being made to the 
research tools as recommended by external independent paediatric dietitian experts (face validity) 
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and the slow recruitment of children into this study; this additional data was invaluable to the study 
sample size. As the amendments did not affect the validity of the dietary intake data already 
collected for these 4 children, this data was included in the analysis.   
 
Good correlation, with no day-to-day or week-to-week variability was seen between the research 
tools for children on diet alone; however variability was seen in children on diet + tube. There were 
too few children in the category of diet + VMS to obtain meaningful interpretation of variability. On 
closer inspection the variability in the diet + tube group was compounded by frequent adjustments 
to feed amounts given to the child. It was found that parents varied tube feed amounts significantly 
particularly during and post chemotherapy and radiotherapy sessions. Flexible tube feeding 
regimens were provided by the Dietitian to accommodate the child’s oral intake as well as side 
effects from treatment; therefore retaining the normality of eating. Parents are encouraged to 
adhere to these suggested volumes to ensure adequate nutrition; however parents are 
autonomous at home. The numbers of adjustments in the tube feeding amounts are also 
associated with the cancer type and nutritional risk. Ninety five percent of the children in this study 
were at high nutritional risk that is indicative of the intensity of treatment regimes and likelihood of 
feed adjustments. A further contributing factor to variability could be due to the 24-hr recall being 
performed 1 week after the EFR. The children undergo many changes from week to week with 
regard to treatment sessions, mucositis, appetite changes, etc. The combination of all these factors 
would explain the poorer correlation in the diet + tube category. Palaniappan(63) suggested that in 
itself the diet alone category experiences inter and intra subject variability however daily and 
weekly oral intakes tend to average. This was demonstrated in the diet alone category; however 
the additional compounding factors associated with diet + tube category are more difficult to 
overcome. As the EFR and the repeated 24-hr recall were highly correlated for the majority of 
categories for protein and energy with significant numbers of children and as it represented four 
days of continuous dietary intake instead of non-consecutive days, further analysis was based on 
the EFR. Future studies with children on diet + tube should recall intake in the same week as the 
EFR. This could potentially improve correlation; however a limitation to this approach would be that 
participants could read off the EFR and not recall intake from memory. 
 
In the 3rd month the increased variability and/or lower correlation could also be due to the poorer 
return rate of EFR’s in comparison to the number of 24-hr recalls obtained. MacIntyre noted that 
the response rate expected from food records was between 65-95% and this was dependent on 
who it was taken from and under what conditions.(64) In this study 71% of the respondents returned 
the EFRs in the 1st month and only 52% in the 3rd month. It can be argued that children receiving 
additional food supplements/tube feeding were in the higher nutritional risk group and therefore 
high risk cancers.(39) The latter will require intensive cancer treatment, potentially more inpatient 
admissions; side effects of treatment and require more time given to feeding in general. In addition 
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the emotional burden on parents caring for a child with cancer would also influence response rates. 
All these factors may influence the time available to complete food records and therefore decrease 
the response rate selectively in this group.  
 
In an effort to reduce variability a useful research tool that could be incorporated in subsequent 
studies is the food frequency questionnaire. This tool accommodates high day-to-day variability. 
This tool was suggested by an independent reviewer of the EFR for the purpose of yielding 
additional information about antioxidant intake. Food frequencies have their niche in targeting 
particular nutrients in question and are preferable in nutrients with a very high day-to-day 
variability. However, they are less sensitive to the absolute intake for specific nutrients and are 
highly reliant on memory.(57) Due to the lack of ‘English’ validated FFQ’s for specifically paediatric 
antioxidant intake this method was not used in this study. Future research could develop and 
validate such a tool and this would be useful in establishing antioxidant intake in this population.  
 
4.2.2 NUTRITIONAL STATUS  
 
The implications of malnutrition in children on cancer treatment are well known. In this study the 
nutritional risk of children against their cancer type showed that 95% were at high risk and only 5% 
at low risk of developing malnutrition. Therefore it could be hypothesised that there would be a high 
prevalence of malnutrition in this study population. However despite the high nutritional risk only 
5% of the children in the 1st month and 10% in the 3rd month fell within the moderately 
malnourished category (<-2 z-score). No children fell within in the severely malnourished group (<-
3 z-score.) The mean z-score of the population of -0.22 and -0.34 was further indicative of a well 
nourished population. Donaldson et al.(5) and Van Eys,(4) presented data on the incidence of 
malnutrition in paediatric oncology children in the range of 6 to 50% depending on the type, stage 
and location of the tumour. Therefore this study population comparatively attained results in the 
lower percentage for malnutrition. Recently a study by Garofola,(65) found that children with Solid 
tumours still achieved higher percentages of deficits for MUAC, weight for height z-scores and arm 
muscle circumference compared to other cancer groups. It is difficult to find specific comparable 
studies due to different cohorts of cancer groups, measurement of malnutrition and cancer staging. 
Factors influencing the ability to find comparable studies/current information on the incidence of 
malnutrition are outlined by Bauer et al;(66) a.) the child’s susceptibility toward malnutrition and 
anticancer treatments during classification, b.) the non-specific definition of malnutrition, c.) the 
stage and histological type of cancer during assessment and d.) the different methods of assessing 
nutritional status. The Solid tumour group showed the greatest prevalence of moderate malnutrition 
in the 3rd month in comparison to the other cancer groups.  It would be reasonable to say that 
despite other studies using different measurement techniques one can compare the prevalence of 
malnutrition.  
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Despite the initial assessment of a high percentage of children being at nutritional risk, few were 
classified as malnourished. This may be due to the nutritional practices in place to prevent 
malnutrition in children admitted to the hospital. One of the possible contributing factors towards 
the prevention of severely malnourished children was the use of the nutritional support algorithm 
(Addenbrookes Hospital; Appendix J). This algorithm clearly shows which children are at greater 
nutritional risk and criteria for early intervention with nutrition support. This algorithm was 
supported by and practised by the whole oncology team and regular counselling was provided by 
the specialist paediatric Dietitians. However without a comprehensive evaluation/audit of this 
algorithm it can only be hypothesised. The key to the success of any research study of this type is 
the implementation of strategies, which will address the areas of nutritional risk for that particular 
population group. 
 
Interestingly, however this study found that children with Leukaemia presented with a higher 
prevalence of obesity in comparison to the other cancer groups. The results showed that 3% of the 
children were overweight (z-score >2) in the 1st and 3rd month. Many studies substantiate these 
findings and are described by Bechard and Mayer et al.(67,68) These authors showed that increases 
in obesity rates were seen in survivors of Acute lymphobastic leukeamia treated with cranial 
radiation. This correlated significantly with decreases in resting energy expenditure and physical 
activity. The second study examined a combination of indirect calorimetry and ambulatory heart 
rate that monitored basal metabolic rate and total energy expenditure.  It was concluded that Acute 
lymphoblastic survivors had a lower energy expenditure and physical activity level than healthy 
children and encountered significant earlier adiposity rebound (body mass index begins to increase 
after its nadir in childhood).(67,69) Studies showed that Acute lymphoblastic leukaemia survivors had 
significantly higher whole body fat percentages, however similar body mass index values 
compared to controls. This suggested the need for body composition measurements to clarify fat 
composition changes in the body.(67)  
 
Weight-for-age was used as a measurement tool to assess the malnutrition status of this study 
population. This gave an indication of current nutritional status, but not of the progression of 
disease, as height measurements were not taken. In this study the height parameter was not used 
as more often than not this routine measurement was not performed for a variety of reasons 
namely; vincristine induced neuropathy which resulted in children being too weak to stand, refusal 
by the toddlers, busy clinics and children attending clinics on a weekly basis and therefore too 
frequent to measure height to determine growth. This was highlighted in a recent audit on the 
children’s wards, auditing the completion of the Paediatric Yorkhill Malnutrition Score (PYMS) 
tool.(70) The PYMS tool was developed and initiated in the UK in an attempt to screen nutritional 
risk in children in the hospital setting. In this study the primary objective was to investigate 
antioxidant, protein and energy intakes; although having a height measurement would be 
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desirable. The absence of this measurement did not impact the results of this study. Though 
weight was primarily used in the weight-for-age z-scores, we need to be mindful that body weight is 
not a sufficiently and adequately sensitive marker for the recognition of nutritional perturbation. 
This is in particular relation to children with large solid abdominal masses (e.g. Neuroblastoma, 
Hepatoblastoma or Wilms tumour) as they may present with a normal weight despite severe 
malnutrition.(66) It may therefore be that the prevalence of malnutrition in this study’s Solid tumour 
population may have been higher if a more sensitive measurement tool was used e.g. MUAC. 
Body weight measurements can also be affected by hydration provided during chemotherapy, 
corticosteroid treatment and oedema therefore masking the loss of skeletal muscle and fat.(66) A 
study by Sala recommended that mid-upper arm circumference and triceps skin folds could also be 
useful in assessing nutritional status, as they were not influenced by the tumour weight and were 
more sensitive than weight alone.(2) MUAC was however not performed in this study as it does not 
form part of routine hospital care for these children. In future studies it would be interesting to use a 
similar demographic of population and measure weight, height, MUAC and skinfold thickness and 
compare the incidence of malnutrition to the results of this study. 
 
An interesting finding from the study was that despite few of the children achieving adequate 
energy intakes (by calculation) across all three feeding modes they did consume very good protein 
intakes and still only presented few children with moderate malnutrition (1st month; n=2 and 3rd 
month; n=4). The article by Scrimshaw relates to this particular finding in describing the close 
interrelationship between energy and protein metabolism.(71) A number of short-term studies had 
shown that protein intake required for nitrogen equilibrium decreased with increasing energy 
intake. This occurred not only when the initial energy intake level was deficient but also when the 
intake exceeded requirements. Conversely, a reduction of protein intake whilst energy intake 
remained constant could reduce the velocity of growth in terms of weight and height, even when 
the nitrogen balance was positive. The mechanisms producing these effects are not clear.  Also 
known is that with an energy intake that is borderline or inadequate, an increase in protein intake 
can result in improved weight gain.(71,72) Energy requirements for maintenance of weight and 
normal body composition may be less when dietary protein is adequate.(71) There is also the 
potential that the calculations used for energy requirements are not adequately predicting what is 
required for these children. Except for post-prandial thermogenesis, protein intake does not have a 
specific effect on energy.(71)  Although no data exists from this study, it may be hypothesised that 
with treatment (in particular radiation) and disease progression that these children may become 
stunted during and after treatment. This is substantiated by findings in two studies examining linear 
growth velocity in children undergoing Hematopoietic stem cell transplantation.(67) In both studies it 
was found that in children undergoing full body irradiation that their final height compared to their 
height pre transplant had decreased in peak height velocity. Some children had achieved a height 
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considered to be within normal parameters. Radiation could therefore be assumed to be the main 
element of growth stunting.   
 
To this day there is still no single ideal tool to accurately measure children or adults nutritional 
status. Attempts to predict the influence of malnutrition based on single measurements fail to 
consider the many interacting factors between nutrition and disease state. Therefore for this 
purpose nutritional status cannot be reliant on one measurement and one needs to use a 
combination of measurements/tools to achieve this. To ensure a comprehensive assessment of 
nutritional status the following criteria should be measured; anthropometry, 
biochemical/haematological variables, clinical and physical assessment and dietary intake.(64) 
 
4.2.3 NUTRITION REQUIREMENT AND NUTRITIONAL SUPPORT 
 
Appropriate dietary assessments and support throughout cancer treatment is essential. This study 
highlighted a consistent trend in the 1st and 3rd month where children on diet alone were put at 
particular risk of antioxidant (except for vitamin C) and energy depletion. One would aim to at least 
achieve the RNI for these antioxidants during chemotherapy. Comparatively the combination of 
diet + VMS achieved the greatest number of children with a significant high intake of vitamins A, C, 
and E. Selenium and zinc intakes did not achieve statistical significance in the number of children 
achieving their RNI for any of the modes of feeding. This is likely to be because of the use of 
vitamin supplements that do not contain these minerals. Kennedy et al.(11) found similar antioxidant 
results to this study population’s i.e. antioxidant intakes were inadequate in children with ALL, 
except for vitamin C. In that study it was reported that throughout the 6-month study period, 
subjects ingested vitamin E, total carotenoid, ß-carotene, and vitamin A in amounts that were 66%, 
30%, 59%, and 29%, respectively, of the US Recommended Dietary Allowance or of the amounts 
specified in the third National Health and Nutrition Examination Survey.(11) Greater vitamin C 
intakes at 6 months were associated with fewer therapy delays, less toxicity, and fewer days spent 
in the hospital. Greater vitamin E intakes at 3 months were associated with a lower incidence of 
infection and greater ß-carotene intakes at 6 month were associated with a decreased risk of 
toxicity.  Kennedy et al.(11) was able to substantiate his findings with plasma antioxidant 
concentrations. In this study adequate levels of vitamin C intakes were shown in every mode of 
feeding. The higher vitamin C results were likely due to the predominant higher intake of fruit juice, 
squash, tube feeds and vitamin supplements from observation of the dietary analysis. 
   
Adequate intakes of vitamin C were seen in all the feeding categories with a minimum of 70% of 
the children achieving their RNI. Children did however also notably consume high vitamin C 
intakes compared to the RNI up to 773% (232mg) in the diet + VMS category and 829% (292mg) 
in the diet + tube category. This does raise concern as to whether the intakes of these children 
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could pose an interference with chemotherapy/radiotherapy and/or toxic levels. The DOH advises 
in broad terms that high intakes in the region of grams/day of vitamin C could cause diarrhoea, 
increased production of oxalate and hence kidney stones (exact grams not specified).(16) Upon 
review, none of the children in this study were achieving greater than 1gram/day. Sixty to eighty 
eight percent of children on nutritional support (i.e. tube feeding and/or food supplements) were 
achieving their RNI antioxidant intakes; except for vitamin A. Vitamin A is closely associated with 
growth. Zinc intake was poor amongst the population with the following percentages of children not 
achieving their RNI respectively 64% (diet alone); 23% (diet + tube) and 57% (diet + VMS). In the 
3rd month the percentage children not achieving their RNI increased to 80% (diet alone), 37% (diet 
+ tube) and 50% (diet +VMS). Once again diet alone had the greatest number of children not 
achieving their LRNI for zinc at 55% in the 1st month and 50% in the 3rd month.  
 
The LRNI results showed a similar trend to RNI, in that the diet alone group had the greatest 
number of children not meeting the LRNI. This was in particular respect to vitamins A and E, 
selenium and zinc. The role of vitamin A and zinc in growth is well documented. They function as 
essential nutrients in cell differentiation, development and linear growth. Numerous studies discuss 
the inhibition of growth in the presence of zinc deficiency. Growth occurs through cell division and 
requires DNA, RNA and protein synthesis. Zinc deficiency could result in reduced production of 
growth hormone  and/or insulin-like growth factor-I.(74,73) MacDonald reported that in animals fed a 
zinc-inadequate diet, both the growth and food intake decreased within 4-5 days.(73) Despite the 
accompanying decrease in growth and food intake, the decreased energy intake was not the 
limiting factor in growth. This was demonstrated by the lack of growth seen in animals force fed a 
zinc inadequate diet. Therefore this shows that food intake and growth are regulated by zinc 
through coordinated and independent mechanisms.(73) Rising et al.(75) noted from their study on rats 
that by giving immunoreactive exogenous recombinant human growth hormone enhanced weight 
gain with suboptimal energy and zinc intake conditions however did not modify energy expenditure 
or physical activity index. A suboptimal zinc intake did not worsen the reduced growth or reduction 
in energy expenditure observed with energy restriction.(75) Vitamin A is also essential in the 
activities of epiphyseal-cartilage cells, which are required to carry out time sequence of growth, 
maturation, and degeneration essential in the mechanism of endochondral or replacement bone 
growth.(76)  The exact effect of vitamin A on the latter was not studied in this study. 
  
In this study the children achieved a lower energy intake than the EAR and an adequate protein 
intake. A comparable Swedish study was undertaken looking at the macronutrient (i.e. energy, 
protein and carbohydrates) intake in malignant children undergoing chemotherapy in relation to the 
Swedish Nutrition Recommendations in the hospital and home environment (SNR).(12) These 
findings showed that the average daily energy intake decreased from 91% of the SNR 
recommendation before chemotherapy to 69% after starting chemotherapy. On the hospital ward 
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only 63% achieved their SNR and despite being discharged home were only able to increase their 
energy intake to 77% of the SNR.(12) It was suggested that growing children and adolescents with 
chronic diseases have increased requirements for energy, protein, fat and carbohydrate, although 
the extent of the increase is not known exactly.(12). A further study by Michaelsen et al.(77) proposed 
that average energy intake for the children with cancer might be about 2 standard deviations above 
the recommendations for healthy children.(12) Unfortunately no exact national recommendations 
exist on the intakes for energy, protein or antioxidant intake, and at what level higher intakes of 
antioxidants could potentially interfere with treatment. One would assume that children on cancer 
treatment should be provided with nutrients to at least achieve their RNI to sustain normal body 
functioning. The DOH advises that if a child’s intake lies between the LRNI and RNI that it is more 
likely that they will have adequate dietary intakes; whereas those children with a habitual dietary 
intake below the LRNI are unlikely to be consuming adequate nutrients to maintain normal body 
functioning.(16) Therefore awareness needs to be raised of the importance of measuring children’s 
height to check for appropriate linear growth, as well as monitoring children for showing any clinical 
signs of deficiency. This should then be confirmed by means of appropriate blood tests. This 
should be considered as additional measurements in future studies. 
 
From the findings of this study it would seem pertinent that detailed dietary analysis and early 
supportive nutrition is needed in cancer treatment. According to a review by El-Mantary,(45) 
aggressive nutritional rehabilitation is very important in improving the outcome in cancer children in 
catabolic states. With an underlying malignancy, in addition to the aggressive chemo- and 
radiotherapy, it is not uncommon to have difficulty in establishing adequate nutrition via the oral 
route.(45) In particular cancer groups it was found that early aggressive nutritional support was 
needed to improve outcome. This was clearly indicated in an publication by Ward et al. about early 
initiation of PEG feeding in children with Medulloblastomas (Solid tumours).(51) These children 
experience significant problems including weight loss, vomiting and constipation early on in 
treatment. One of the centres in the study demonstrated a superior nutritional outcome when 
compared statistically to the two centre’s that fed only as a response to nutritional decline. 
Nutritional assessment and support should be integrated into treatment protocols for all children 
with neoplastic diseases.(47) 
 
In children with cancer much emphasis is placed on ensuring growth and therefore the focus is 
shifted to energy and protein intake. This over-shadows the equally vital intake of micronutrients. 
Ensuring an adequate intake of macro- and micronutrients becomes challenging with a child 
experiencing side effects of decreased appetite, taste changes, vomiting and nausea.(1) Without 
guidance on requirements for vitamins and minerals in cancer treatment this is often a neglected 
area of nutrition.  
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4.2.4 VITAMIN AND/OR MINERAL SUPPLEMENTATION 
 
The consumption of vitamin-mineral supplements was surprisingly low in this study population 
namely 27% in the 1st month and 18% in the 3rd month in comparison to other similar studies. This 
study did not determine the reasons for vitamin and mineral consumption as this was not one of 
the main objectives. Recent surveys of children with cancer demonstrated that 25% to 84% used 
nutritional supplements containing antioxidants and often at doses higher than the RDA.(78) Further 
to that survey, studies by Bussieres et al.(79) and Mottonen et al.(80) showed that 20% and 40% 
respectively of their children used vitamins. Mega-dose supplementation of vitamin B complex, C, 
and E was documented in the studies by Kennedy et al.(11) and Neuhouser at 36% and 28% 
respectively of the study population.(81)   
 
Routinely children on the ward request advice on vitamin-mineral supplements, however as no 
concise evidence on actual dosing is available, the general advice from healthcare professionals 
may vary. The general advice includes when you may want to consider vitamin-mineral 
supplements e.g. poor oral intake, limited variety in diet. No singular vitamin or mineral supplement 
is usually recommended instead a general vitamin – mineral supplement that does not exceed the 
RNI. Ward,(1) recommends that until further studies are published on the role of antioxidants and 
interactions that it is sensible that vitamins and mineral should not be supplemented above the 
RNI. Parents are more aware of vitamin and mineral supplementation when their child has cancer, 
especially antioxidants. The rationale for using antioxidants during treatment is to ameliorate the 
side effects and depletion of antioxidants during treatment. There are however numerous 
publications to suggest that increased amounts of antioxidants may potentially interact with the 
chemotherapy and radiotherapy and the way in which it causes apoptosis in the cells. Kennedy et 
al.(11) does not advocate supplementation during treatment with antioxidants due to the probable 
interference with cancer treatment; despite their study showing that the population group did not 
meet recommended dietary intakes. The study by Kennedy et al.(11) did not make reference to 
whether supplementation insinuated excessive supplementation or supplementation to established 
RNI requirements.  
 
Comparison of the children’s fat-soluble vitamin intakes to safe upper ranges showed no excessive 
intakes (vitamins A and E). It is known that fat-soluble vitamins taken at recommended amounts on 
a daily basis are essential to maintain good health; however mega-doses could be toxic. This is 
due to the body’s ability to store fat-soluble vitamins for long periods and therefore posing a greater 
risk of toxicity than with water soluble vitamins when consumed in excess. Although vitamin-
mineral supplements were used by this study population, it was at a low prevalence in comparison 
to other similar studies. None of the children exceeded the guidance for maximum intakes of 
antioxidants. 
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CHAPTER 5 CONCLUSIONS AND RECOMMENDATIONS 
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Nutritional support in cancer treatment remains a complex subject. New research is keenly awaited 
to demystify the theory of antioxidant interference in cancer treatment and the actual requirements 
needed during illness. This also pertains to the actual requirements for calories and protein intake 
for children with cancer.  
 
In this study a large proportion of the children undergoing treatment for Leukaemia, Lymphoma and 
Solid tumours displayed inadequate intakes of antioxidants and energy. The diet alone feeding 
mode was highlighted as the most nutritionally depleted in antioxidants and energy. This was a 
consistent trend seen both at diagnosis and 3 months into treatment. The consequences of 
malnutrition (increased side effects, infections, mortality and morbidity) are well documented and 
are multiple in children who are undernourished compared to these well-nourished during cancer 
treatment. Vitamin A and zinc were highlighted as especially depleted in the diet alone mode. It is 
known from numerous published studies on vitamin A and zinc, that poor growth (in particular 
linear growth) is seen in vitamin A and zinc deficiency. On the other hand vitamin C in particular 
with lower proportions of other antioxidants were achieving greater than 200% of the RNI and in 
some instances up to seven times the RNI. This was found specifically with the children on diet 
plus vitamins and/or mineral supplements. The data showed that there was a tendency towards the 
use of vitamin supplements and not mineral and trace element supplementation that may explain 
inadequate intakes of selenium and zinc. It therefore highlighted the need for education with regard 
to wiser choices of vitamin and mineral supplement purchases, if children require a supplement. 
High intakes of antioxidants (vitamin C) and in some cases vitamin A and E raised the issue of 
toxicity if used on a long term basis but also most importantly the controversial debate around the 
interference of antioxidants in apoptosis during chemotherapy and/or radiation. This is a real 
dichotomy.  
 
A weakness of this study was its inability to obtain the full set of EFR’s and 24-hr recalls for data 
analysis. However it is known that EFR’s have a poorer return rate and taking into account the 
burden that cancer treatment places on children and their families, it would seem understandable 
given the context. The data collection periods were in the 1st and 3rd months of diagnosis, 
however in some cases children were not discharged from hospital within the allotted time frames 
due to infections or the type of treatment they were receiving. This was particularly seen in the 
AML and Non-hodgkins lymphoma cancer groups. This in turn affected the time frame in which the 
24-hr recall and subsequent EFR2 could be completed and returned. Only once the 24-hr recall 
was completed could the parents complete the EFR. Similarly the time frames were not always 
exactly adhered to due to children being re-admitted for their treatment block, infections, 
neutropenia or surgery, among other reasons. This influenced the continuity of data collection.   
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The EFR and 24-hr recall correlated well with particular reference to diet alone (vitamin A, C, E and 
zinc, energy and protein). However the EFR and 24-hr recall were limiting in their ability to obtain 
similar data between the two weeks in the diet + tube category. This was highly influenced by the 
significant day-to-day and week-to-week variability of children’s’ nutritional intake and side effects 
and hence the need for feed adjustment. As previously discussed, the Dietitians provided a flexible 
feeding regimen to accommodate for variable oral intake and parents were autonomous at home. 
Although it may be perceived as a limitation that not both the 24-hr recall and EFR were analysed 
for the diet + tube group, the researcher found, that there were such significant differences even 
between the repeated 24-hr recalls (parents varied the tube feeds), that the EFR would provide the 
most reliable data and that the addition of the repeated 24-hr recall would not add any further 
information. 
 
A significant shortcoming for this study and other similar studies was the lack of National 
Standards for antioxidant, protein and energy intakes in children with cancer. The Dietary 
Reference Values consist of a series of estimates of the amount of energy and nutrients needed by 
different groups of healthy children in the UK population. However this does not taken into account 
potential increased needs of sick children. Probable difficulties in determining standards for sick 
children are the numerous variables; disease type and stage, age, gender, level of physical 
activity, ability to absorb and utilise nutrients etc.  
This study showed that the majority of children receiving nutritional support (tube feeds and/or food 
supplements) achieved their RNI intakes for antioxidants, energy and protein.  Conversely children 
on diet alone displayed poor intakes of these nutrients. Further studies will be required to 
determine the clinical implications of these findings. One hypothesis to be tested would be that 
children who are receiving optimum nutritional support experience fewer infections, decreased 
length of stay and fewer dose adjustments to treatment. A large number of children would be 
needed to investigate this and collaboration of many centres would be required. The clinically 
useful outcomes, for which such a study should be powered, might include: 
1.  A reduction in the length of stay per cycle of chemotherapy by ≥ one day in the intervention 
versus non-intervention group 
2.   A reduction in infections in the intervention group. 
3.   A reduction in dose adjustments in the intervention group.   
Many factors would have to be controlled in such a study such as type of treatment, pre-existing 
morbidities, nutritional status at outset etc. To our knowledge no study of this nature has been 
conducted before.  
Stellenbosch University  http://scholar.sun.ac.za
63 
 
From this study a recommendation to the local cancer team, would be to devise an educational 
leaflet for the patient/parents stating the findings of the study, with appropriate means of improving 
both energy and antioxidant intake to meet the RNI and EAR. This would also include education to 
the cancer unit team to ensure that the findings of the project are known and that consistent 
education is provided to parents. A small addition to the nutritional algorithm would be to include 
the prompt of starting a vitamin-mineral supplement if eating limited fruit and vegetables and at a 
low nutritional risk and healthy eating if excessive weight gain is seen and consideration of an 
alternative method of measuring malnutrition for e.g. MUAC especially in children with Solid 
tumours. This will also raise awareness of the need for consistent growth monitoring and noting 
any clinical signs of deficiency. Upon forwarding recommendations to the cancer unit team, it 
would be recommended that the study be repeated to determine whether a greater percentage of 
children are meeting their RNI requirements. 
.  
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ADDENDA 
 
Addendum A: Summary of each antioxidants function, source, nutritional state and requirement 
Antioxidant Functions Nutritional State Sources Requirement 
Vitamin A 
• Essential for normal 
development and 
differentiation of tissues.(17, 
82)
 
 
• Excessive intakes of retinol cause liver 
and bone damage, hair loss, double 
vision, vomiting, headaches and other 
abnormalities 
• Vitamin A deficiency common in 
developing countries  
• Obvious signs of deficiency are dryness 
of conjunctiva and cornea Can lead to 
permanent eye damage 
• Primary deficiency - characterized by 
impaired embryonic development, 
impaired spermatogenesis, 
spontaneous abortion, impaired 
immune competence.  
• Secondary deficiency - results from  
malabsorption due to insufficient dietary 
• Pre-formed vitamin 
A i.e. liver, milk 
and eggs 
• Pro-vitamin A i.e. 
dark green leafy, 
and yellow-orange 
vegetables and 
fruit 
• Cod, halibut  
(very high 
concentration)   
(16, 17) 
Regular intakes should 
not exceed:  
1800ug (1-3years old) 
3000ug (4-6years old) 
4500ug (6-12years old) 
6000ug (adolescents)  
See DRV in Addendum 
B  
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Antioxidant Functions Nutritional State Sources Requirement 
fat, biliary, or pancreatic insufficiency 
• Prolonged deprivation leads to death(16, 
17, 82, 83)
 
Vitamin C 
• Prevents scurvy and aids 
wound healing 
• Assists absorption of non-
haem-iron 
• Important antioxidant(16) 
• Excessive intakes of grams/day lead to 
increased production of kidney stones 
(oxalate predominant) 
• Frank deficiency (scurvy) rarely seen in 
UK(16, 83) 
• Citrus and soft 
fruits, growing 
points of 
vegetables(17) 
 
 
See DRV in Addendum 
B 
Vitamin E 
• Principal function as 
antioxidant (especially in 
lipid soluble 
membranes)(84) 
 
 
• Few adverse effects from doses up to 
3200mg/day (not consistently seen) 
• Clinical manifestations of deficiency 
vary.  In general targets neuromuscular, 
vascular, and reproductive systems 
• Clinical deficiency is rare and only 
clearly identified in premature infants(17, 
20, 83)
 
• Nuts, seeds, and 
vegetable oils, 
green leafy 
vegetables and 
fortified cereals 
 
S 
safety of high levels to 
be established 
(Addendum B) 
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Antioxidant Functions Nutritional State Sources Requirement 
Selenium  
• Essential part of 
glutathione peroxidise 
(GSHPx) 
• Anti-carcinogenic 
properties 
• Stimulation of immune 
functions i.e. lymphocyte 
proliferation, reduces 
pathogenicity of viral 
agents  
 
• Levels in excess of 100ug/dL lead to 
selenosis. Symptoms include: hair loss, 
white blotchy nails, fatigue, irritability, 
mild nerve damage, gastrointestinal 
upsets 
• Deficiency rare in humans and may take 
years to develop. Repletion occurs 
within weeks or months 
• Considerable interaction occurs between 
selenium and vitamin E.  If high doses of 
Vitamin E are ingested, this decreases 
the effects of selenium deficiency(83, 85) 
• Cereals, seafood, 
meat 
• Concentration of 
selenium in food 
dependent 
selenium content 
of soil an soil type 
• Vegetables, fruits 
and beverages 
are generally low 
in selenium (83, 86) 
 
 
•  Margin between 
selenium 
requirement and 
deficiency narrower 
than most trace 
elements; therefore 
high risk of toxicity in 
over-
supplementation (83) 
See DRV in Addendum 
B 
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Antioxidant Functions Nutritional State Sources Requirement 
Zinc Structural, catalytic, regulatory 
role in many enzymes 
• Structural role in non-
enzymatic  proteins 
• Maintains configuration of 
mammalian gene 
transcription proteins and 
integrity of biomembranes 
• Involved in major metabolic 
pathways for the 
metabolism of protein, 
carbohydrate, energy, 
nucleic acids and lipids(16) 
Chronic ingestion of 75-300mg/day (1.15-
4.59mmol/d) associated with copper 
deficiency features i.e. microcytic anaemia, 
neutropenia. 
• Short term studies show 50mg 
(0.76mmol) interferes with metabolism of 
iron and copper 
• Overt deficiency rare 
• Subclinical deficiency common 
especially with tissue injury, surgery, 
infection, low dietary intake (eating and 
swallowing difficulties). (16, 83) 
 
Meat, fish, poultry, 
milk and milk products 
• Fairly good 
sources 
oysters,  
cheese, 
wholegrain 
cereals, dry 
bean, nuts 
• Body dependent 
on regular 
dietary supply 
(no specific 
zinc reserve). 
(87)
 
 
See DRV in Addendum 
B 
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ADDENDUM B: Dietary reference values for vitamin A, C, selenium and zinc and safe intake for 
vitamin E 
 
Dietary reference value for vitamin A (ug retinol equivalent/day)(16) 
 
Age (years) Lower Reference Nutrient Intake 
Estimated Average 
Requirement. Reference Nutrient Intake 
1-3  
4-6 
7-10 
 
Males 
11-14 
15-18 
 
Females 
11-14 
15-18 
200 
200 
250 
 
 
250 
300 
 
 
250 
300 
300 
300 
350 
 
 
400 
500 
 
 
400 
400 
400 
400 
500 
 
 
600 
700 
 
 
600 
600 
 
 
Dietary reference value for vitamin C (mg/day)(16) 
 
Age (years) Lower Reference Nutrient Intake 
Estimated Average 
Requirement Reference Nutrient Intake 
1-3 
4-6 
7-10 
 
Males 
11-14 
15-18 
 
Females 
11-14 
15-18 
8 
8 
8 
 
 
9 
10 
 
 
9 
10 
20 
20 
20 
 
 
22 
25 
 
 
22 
25 
30 
30 
30 
 
 
35 
40 
 
 
35 
40 
Dietary reference values for selenium (ug/day)(16) 
Age (years) Lower Reference Nutrient Intake Reference Nutrient Intake 
1-3 
4-6 
7-10 
11-14 
Males 
15-18 
Female 
15-18 
7 (0.1) 
10(0.1) 
16(0.2) 
25(0.3) 
 
40(0.5) 
 
40(0.5) 
15 (0.2) 
20(0.3) 
30(0.4) 
45(0.6) 
 
70(0.9) 
 
60(0.8) 
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Dietary reference values for zinc (mg/day)(16) 
Age (years) Lower Reference Nutrient Intake 
Estimated 
Average 
Requirement 
Reference Nutrient Intake 
1-3  
4-6 
7-10 
 
Males 
11-14 
15-18 
 
Females 
11-14 
15-18 
3.0(45) 
4.0(60) 
4.0(60) 
 
 
5.3(80) 
5.5(85) 
 
 
5.3(80) 
4.0(60) 
3.8(60) 
5.0(75) 
5.4(80) 
 
 
7.0(110) 
7.3(110) 
 
 
7.0(110) 
5.5(85) 
5.0(75) 
6.5(100) 
7.0(110) 
 
 
9.0(140) 
9.5(145) 
 
 
9.0 (140) 
7.0(110) 
 
 
Safe intake for vitamin E (mg α-tocopherol equivalent/day) 
 
 
Age (years) 
 
Vitamin E (mg α tocopherol) 
 
Males 
1-3 years 
4-6years 
7-10years 
11-14years 
15-18years 
 
3.2 
4.9 
5.6 
6.4 
8.0 
Female 
1-3 years 
4-6years 
7-10years 
11-14years 
15-18years 
 
3.2 
4.3 
5.0 
5.3 
6.1 
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ADDENDUM C:  Estimated Average Requirements for energy and protein (16) 
 
Age (years) Energy (kcal)  
 
Protein (g) 
 
Males 
1-3   
4-6  
7-10  
11-14  
15-18  
 
1230 
1715 
1970 
2220 
2755 
 
14.5 
19.7 
28.3 
42.1 
55.2 
Female 
1-3   
4-6  
7-10  
11-14  
15-18  
 
1165 
1545 
1740 
1845 
2110 
 
14.5 
19.7 
28.3 
41.2 
45.4 
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ADDENDUM D:  Safe Upper intake for vitamin A and E  
 
Safe Upper Intakes for vitamin A (ug retinol equivalents/day) should not exceed:(16) 
 
 
Age (years) 
 
Vitamin A(ug retinol 
equivalents/day) 
 
Infants 
1-3 
4-6 
6-12 
Adolescents 
900 
1800 
3000 
4500 
6000 
 
Safe Upper Intake for vitamin E (mg α-tocopherol equivalent/day)(16) 
 
Few adverse effects have been reported from doses of vitamin E up to 3200mg/day  
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ADDENDUM E: Invitation letter to study 
 
Department of Nutrition and Dietetics 
Box 119 
 
Tel: 01223 216655 
Fax: 01223 216824 
 
 
 
 
 
 
DEAR PARENT/CARER AND CHILD 
 
As part of my Master in Nutrition, I hereby invite you to participate in a research project that is currently underway 
at the University of Stellenbosch, South Africa.  The research topic being researched is: Antioxidant Intake in 
Paediatric Oncology Patients.  
 
This research study has been approved by the Hertfordshire Research Ethics Committee, England (project nr: 
08/H0311/53) and by the Committee for Human Research, Faculty of Health Sciences, Stellenbosch University, 
South Africa (project nr: N08/04/094). 
 
There is widespread interest in the role that antioxidants play in the prevention and course of cancer treatment. 
There is very little data available on the nutritional requirements for antioxidants in children and much is 
extrapolated/taken from work done in adults. There are two particular schools of thought about antioxidants and 
cancer treatment; i.e. Antioxidants play a beneficial role in improving cancer treatment tolerance, reduce 
infections and less frequent delays in treatment occur, whereas the other school of thought is that antioxidants 
may interfere with the efficacy of certain cancer treatments.  
 
In this study we will be determining if your child’s antioxidant intake is meeting the recommended nutrient intake 
for antioxidants as recommended by the Department of Health. 
 
To determine your child’s antioxidant intake, would you be willing to complete two 4-day Food Records (issued 
within first month after diagnosis and three months later)?  The Primary Investigator, Sonja Slegtenhorst will 
provide you with the Food Records and a date to start recording in the Food Record.   This will enable us to 
determine your child’s antioxidant intake at different periods of the treatment.  The week prior to starting the 
Food Record the Primary Investigator will call you by telephone (on the Monday, Wednesday, Friday and 
Sunday) to recall your child’s previous 24-hr recall of food and fluid intake. These telephone calls will be of a 
short duration and will serve to validate/reference the Food Record. 
 
Participation in this study is voluntary and patients are able to withdraw without this affecting their treatment. 
Any information gathered would be useful in contributing to current dietetic practice and has the potential to 
improve nutritional management of the paediatric cancer patient. 
 
How to reply: 
Please complete the 4-day Food Record and return it in the prepaid envelope to: 
Sonja Slegtenhorst 
BOX 119. Addenbrookes Hospital, Nutrition and Dietetic Department. 
Hills Road. Cambridge 
CB2 0QQ 
 
Your participation is greatly appreciated.  Should you have any queries with regard to this research study or the 
completion of the food record please contact Sonja Slegtenhorst at tel: 01223 216655 
 
Yours sincerely 
 
Sonja Slegtenhorst 
Paediatric Dietitian 
Addenbrooke’s NHS Trust 
Hills Road 
Cambridge CB2 2QQ 
 
Tel: 01223 245151 
www.addenbrookes.org.uk 
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ADDENDUM F: Information sheets used in study 
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ADDENDUM G: Consent form 
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ADDENDUM H: Estimated Food Record 
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ADDENDUM I: 24 Hour recall 
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ADDENDUM J: Nutritional Support Algorithm (Addenbrookes Hospital)  
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ADDENDUM K: Critique forms  
Critiqued by Vanessa Shaw (Head of Dietetic Department, Great Ormond Street Hospital) and Anita MacDonald (Head of Dietetics at 
Birmingham Children’s Hospital) 
Question        Yes     No                  Comments 
Does the EFR meet the following requirements: 
a. Clearly indicate number of days to be 
completed 
  
√ 
I think the first page is very busy. I think it should say it is a 4 day record and 
then put brackets that are 3 week days and 1 weekend day. I think it would 
be better to specify the days 
In your protocol you say that you want the EFR completed on 
consecutive days ie Wed, Thu, Fri, Sat. If you want intake for these 
specific days recorded you should indicate this on the front page. 
b. Elicits information on the type, dose, and 
frequency of vitamin/mineral supplements? 
√ √ I think it would be better to put: 
• Any vitamin & mineral supplements?     Yes            no 
• What is the name_________________ 
• How much do you give each day 
• Do you give it every single day         
• Comments 
c. Clearly states that any relevant vitamis 
and/or mineral supplement packaging 
should be returned with the EFR? 
 √ Note is unclear – needs rewording 
No need for the *Note. Just add preparation information leaflet to the 
next instruction line 
d. Clearly indicates the address to where the 
EFR and vitamin and/or mineral packaging 
should be returned.  
√   
General contents: 
a. Is it clear how to document: 
b. – portion sizes 
c. Leftovers 
d. Amounts 
e. Preparation, amount and type of tube feed 
and/or vitamin and/or mineral supplements 
 √ • Maybe not a good idea to give rashes of bacon as an example of 
food as unacceptable to Muslim families. Would have been a good 
idea to include a double check for types of common foods used it the 
diet, e.g. type of milk, spread used e.g. butter, margarine, low fat 
spread, type of squash/cold drink(how many drinks per day on 
average). This would have provided useful information. Need to ask 
children to state brand of food even save food labels.  
• pump’s memory 
• Time feeds were given - do you mean eg, rather than ie? 
• You need to define cup. This could be interpreted as a teacup, a 
mug or an American cup (as used in recipes). 
Stellenbosch University  http://scholar.sun.ac.za
 101 
 
• Need to ask which type of milk is used in tea etc. How many 
teasp of sugar, drinking chocolate? 
• Day’s meals 
• How much Ribena/squash in the drink? 
• Give 2 pages for each day -  not much room for people who 
have big and untidy handwriting  
 
Checklist page 
Does the checklist help the parent/guardian to 
recall items that may have been missed whilst 
documenting in the EFR? 
√  Why mention protein as a food group? You haven’t included other food 
groups. Will all families know what you mean by dairy? Eaten appears 
twice in this sentence. 
 
Spreads eg not ie 
 
• Why do you have blank pages – 2, 11, 12 
Is the EFR user friendly? √ √ Too crowded. A lot of detail but not spread out enough.  
But give more examples on page 4. Did you mean there to be no milk 
added to the Weetabix? Is sugar added? Say how much Ribena is in 
the 100ml drink. Give an example of tea plus milk plus sugar. Give an 
example of a sandwich so that they can see that they need to record 
how many slices of bread, butter added, filling added  - you don’t want 
an entry just to read ‘1 cheese sandwich’. 
 
Does the EFR elicit information pertaining to the 
studies objectives? 
√  Yes, but a food frequency diary may have yielded additional information 
about antioxidant status.  
But intake of food and drink needs to be more accurately recorded 
than you have indicated. 
Use in other studies 
Is the EFR reproducible in other similar studies? 
√  With the above modifications. 
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Addendum L Approval letter for Human Research Committee of Stellenbosch University  
                       (South Africa) 
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Addendum M Approval letter from the Hertfordshire Research Ethics Committee (England), R & D  
                       Department (Addenbrookes Hospital) and Sponsorship letter 
                                                                                              Hertfordshire REC 
                                                                                                            East of England REC Office No 3 
                                                 9th Floor, Terminus House 
          The High 
                                                                        Harlow 
                                            Essex 
                                                                              CM20 1XA 
 
                                                                                        Tel: 01279 418439 
                                                                                         Fax: 01279 419246 
 
07 April 2009 
 
Dr Rosan M Meyer 
Specialist Paediatric Dietitian 
Imperial College School of Medicine  
St.Mary’s Hospital Campus 
Room 252, Norfolk Place 
London 
W2 1BG 
 
Dear Dr Meyer 
 
Study title: Antioxidant intake in Paediatric Oncology Patients with Solid 
Tumours and Lymphomas 
REC reference: 08/H0311/53 
Amendment number: 2 
Amendment date: 03 January 2009 
 
The above amendment was reviewed at the meeting of the Sub-Committee of the REC held on 03 April 
2009. 
 
Ethical opinion 
 
The members of the Committee present gave a favourable ethical opinion of the amendment on the basis 
described in the notice of amendment form and supporting documentation. 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
 Document  Version  Date  
Protocol  3  03 January 2009  
Notice of Substantial Amendment (non-CTIMPs)  2  03 January 2009  
  
Membership of the Committee 
 
The members of the Committee who took part in the review are listed on the attached sheet. 
 
R&D approval 
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All investigators and research collaborators in the NHS should notify the R&D office for the 
relevant NHS care organisation of this amendment and check whether it affects R&D approval 
of the research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees (July 2001) and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 
08/H0311/53:     Please quote this number on all correspondence 
 
Yours sincerely 
 
Mrs Jenny Austin 
Committee Co-ordinator 
 
E-mail: jenny.austin@eoe.nhs.uk 
 
Enclosures List of names and professions of members who took part in the 
review 
 
 
 
Copy to: Sonja Slegtenhorst 
Specialist Paediatric Dietician 
Addenbrookes Hospital 
Hills Road 
Cambridge 
CB2 0QQ 
 
Dr John Bradley 
Box 277 
Cambridge University Hospital NHS Foundation Trust 
Addenbrookes Hospital 
Hills Road 
Cambridge 
CB2 0QQ 
Hertfordshire REC 
 
Attendance at Sub-Committee of the REC meeting on 03 April 2009 
 
Name   Profession   Capacity    
Dr Steve Eckersall  Consultant Anaesthetist  Expert  
Mrs Vivien Felgate  Senior Pharmacist  Expert  
Dr Sunda Uthayakumar  Consultant Physician HIV & GUM  None  
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Addendum N Comparison of Antioxidant Intakes to the Dietary Reference Values and Safe Intakes (1ST and 3rd month) 
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Addendum O Comparison of Antioxidant Intakes to the Lower Recommended Nutrient Intakes (1st and 3rd month) 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 113 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 114 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 115 
 
Addendum P Comparison of Energy and Protein to the Estimated Average Requirements (1st and 3rd month) 
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